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A brief summary of the work described in this thesis
is given below
The sterol mono-oxygenase studied in this investigation
was the cholesterol side-chain cleavage enzyme system of
human term placenta.
(a) A rapid and sensitive assay of cholesterol side-chain
cleavage activity is described.
(b) The enzyme system was found to be located in the mito¬
chondrial fraction and to have the characteristics of a mond-
oxygenase or "mixed function oxidase", i.e. required NADPH
and molecular oxygen.
(c) Using native placental mitochondrial preparations,
the effect of various intramitochondrial sources of reducing
equivalents and also other reducing agents on the enzymic
activity was examined.
(d) The enzyme system was successfully extracted in a
soluble fraction using three different techniques, viz , ultra-
sonication, a combination of ultrasonication and lyophilization
and acetone powder preparation.
(e) Disruption of the mitochondria led to the activation
of an endogenous inhibitor of the enzyme system. The
inhibitor was firmly associated with the particulate material
and appeared to be mitochondrial phospholipid. Lecithin was
found to be the most potent phospholipid inhibitor. A
mechanism for the inhibition is discussed.
(f) The characteristics of the *solubilised' enzyme
system have been investigated with special consideration
being given to the effect of NADPH and ionic strength on
the enzymic activiey as well as the activation energy of
the reaction.
(g) The enzyme system was found to be sensitive to carbon
monoxide. A study of data on the release of this inhibition by
lighc of various wavelengths implied the involvement of
cytochrome P-ij.50 in the enzyme system.
(h) The soluble enzyme system was resolved into three
protein fractions - a haem-containing fraction (presumably
cytochrome P-i|50), a non-haem iron protein and an NADPH
diaphorase fraction. The enzymic activity was restored after
recombination of these three protein fractions.
The human placental mitochondrial cholesterol side-
chain cleavage enzyme system, therefore, appeared similar
to the enzyme system present in bovine adrenal cortex and
rat ovary.
(i)
ABBREVIATIONS USED IN THE TEXT
The following standard abbreviations will be
used throughout the text:-
NADP+ - nicotinamide-adenine dinucleotide phosphate
NADPH - reduced niootinamide-adenine dinucleotide
phosphate
NAD - nicotinamide-adenine dinucleotide
NADH - reduced nicotinamide-adenine dinucleotide
G6P - D-glucose-6-phosphate disodium salt
G6PD - D-glucose-6-phosphate dehydrogenase
ACTH - adrenocorticotrophic hormone
GSH - reduced glutathione
ATP - 5*-adenosine triphosphate
PPO - 2,5-diphenyloxazole
POPOP - l,ip-bis (2- (5-phenyloxazolyl))-benzene
TLG - thin-layer chromatography
GLG - gas-liquid chromatography







Enzymes that incorporate one atom of molecular oxygen
into substrates while concomitantly reducing the other atom
to water are termed mixed-function oxidases (Mason, 1957*
1965) or mono-oxygenases. The stoichiometry of this type of
reaction may be represented as follows:
RH + °2 + H2A » R - OH + A + H20 (A)
RH is the substrate and, in most instances, the reductant;
H2a is either reduced nicotinamide-adenine dinucleotide
phosphate (NADPH) or reduced nicotinamide-adenine dinucleotide
(NADH). The importance of mono-oxygenases in metabolism is
evident from the wide range of substances with which they
react - such as, carbohydrates, lipids, amino acids, steroids,
drugs and hormones. The nature of mixed function oxidase-
catalyzed reactions has been reviewed by Mason (1965), and is
the topic of several reviews (King et al., 1965; Bloch and
Hayaishl, 1966; Konstanz Symposium on the "Mechanisms of
Mixed Function Oxygenation", 1968). Although considerable
effort in the past decade has been devoted to the enzyme
components, coenzymes and cofactors required for oxygenation,
the reaction mechanism of mono-oxygenases at the molecular
level remains poorly understood. Studies have been compli¬
cated by both the particulate nature and the lability of the
enzyme components. Although in a few cases the systems with¬
in which mixed-function reducing equivalents are brought into
reaction with oxygen and substrate are soluble, such as
phenylalanine hydroxylase (Kaufman, 1962) and camphor oxidase
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(Katagiri et_aJU, 1968), they are usually associated with
organised subcellular structures. In higher organisms,
this is either the mitochondrion or the endoplasmic reticulum.
For certain mixed-function oxidases it has been possible
to determine the precise stolchiometry of the reaction sequence
(A). The electron donor in many mammalian mono-oxygenase
systems is NADPH, but NADH can serve as a source of reducing
equivalents in certain cases.
Hydroxylases
Hydroxylases belong to the class of mixed-function
oxidase enzymes. Enzymic hydroxylation refers to the intro¬
duction of a hydroxyl group into various substrates and is
catalyzed by different types of enzymes. The source of
oxygen in the hydroxyl group may be derived from (a) molecular
oxygen, (b) an oxygen atom of a water molecule, or (c), possibly,
from some other compound. Certain aspects of the
metabolism of lipids and aromatic compounds are often
initiated by hydroxylation. These compounds apparently need
to be oxygenated in order to become biologically active or
more soluble in an aqueous environment. But, possibly because
of their hydrophobic nature, molecular oxygen seems to be the
preferred hydroxylating agent rather than water. ki/hen the
oxygen atom of the hydroxyl group is derived from molecular
oxygen, the enzyme is, by definition, an oxygenase. Mono-
oxygenases are concerned with hydroxylation reactions of
aromatic as well as aliphatic compounds. They also catalyze
an apparently diverse group of reactions including epoxide
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formation, N- or S-oxide formation, dealkylation, decarboxyl¬
ation, deamination, desaturation and so forth. Though the
overall reactions catalyzed by mono-oxygenases appear grossly
different, the primary chemical events involved are basically
identical since all the processes are initiated by the incor¬
poration of one atom of molecular oxygen into the substrate
(Guroff et al., 1967).
In mammals, mono-oxygenases are located in certain
specific organs and subcellular particles. Many of the
enzymes involved in the hydroxylation of physiological
substrates and the enzymes that take part in the hydroxylation
(detoxification) of foreign compounds are located in the liver
endoplasmic reticulum (Gillette et al., 1969). Certain
selective hydroxylations are also carried out by liver
mitochondria (Salto et al., 1957).
Mono-oxygenases are also found in the steroid-producing
tissues (adrenals, gonads and placenta) and play an important
role in steroid metabolism. In these tissues, they are
associated with both the mitochondria and the endoplasmic
reticulum (see Dorfman and Ungar, 1965).
Enzymic hydroxylation has recently been reviewed by
Hayaishi (1969) .
Sterol and Steroid mono-oxygenases
Hydroxylation reactions pertaining to mammalian
steroid metabolism have been noted at carbons 7a, 20a, 22R
and 26 in cholesterol and at carbons 2a, 2 (aromatic),
6a, 60, 7a, lip, 15a, 16a, 160 (possible, but not certain),
17a, 18, 19 and 21 in other steroids. With the
suitable deoxy-steroid substrate it is likely that
k
hydroxylation could be shown to occur at any position on the
steroid molecule (Dorfman and Ungar, 1965)•
There is considerable evidence that the source of re¬
ducing equivalents for mammalian steroid mixed-function
oxidases is NADPH (Ryan and Engel, 1957; Sweat and Lipscomb,
1955). The requirement for molecular oxygen was demonstrated
by Hayano et al. (1955) ",Ib-o showed the incorporation of
1 R
molecular 0^ during the 110-hydroxylation of deoxycortico¬
sterone. Cooper et al. (1962) established the validity of
the stoichiometry of the *mixed-function oxidase* Equation
proposed by Mason (1957)* i.e.
RH2 + 2e + 2H+ + 02 > R - OH + HgO
These workers showed that for the steroid 21-hydroxylase the
ratio of NADPH oxidised to 17a,21-dihydroxyprogesterone
produced to the 02 reduced is 1:1:1, as predicted by the
above equation.
The most thoroughly studied mammalian steroid hydroxylase
is the 11^-hydroxylase which is found in the mitochondria of
the adrenal cortex. However, the first indication as to the
nature of steroid hydroxylases came from an observation of
Ryan and Engel (1957) that the 21-hydroxylation of 17<x-hydroxy-
progesterone occurring in adrenocortical microsomes was
inhibited by carbon monoxide, and that this inhibition was
reversed by light. In 1958, Garfinkel and Klingenberg in¬
dependently observed an intense ligjat absorption band at
14-50 nm when liver microsomes reduced with dithionite were
gassed with carbon monoxide. Estabrook et al. (1963) observed
a similar type of I4.5O nm-absorbing pigment when adrenal
Wavelength (m/x)
Pig. 1.1. The difference spectrum of the CO-complex of
cytochrome P-ijjpO of bovine adrenocortical
microsomes. The difference in light absorbancy
was determined as a function of wavelength; a
reaction cuvette containing NADPH was gassed with
GO; a reference cuvette contained NADPH.
After Estabrook et al. (19&3).
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microsomes were treated with NADPH and carbon monoxide.
This pigment was shown to be a protoporphyrin haemoprotein
of the cytochrome b type and named cytochrome P-I4.5O by Omura
and Sato (196i|a,b). Figure 1.1 shows a typical difference
spectrum of the reduced, carbon monoxide complex of this
haemoprotein. Estabrook et al. (1963) further demonstrated
that cytochrome P-450 was the terminal oxidase involved in
the steroid 21-hydroxylation reaction.
The Function of Cytochrome P-U.50 in Mono-oxygenase-catalysed
Reactions
Estabrook et al. (1963) studied the carbon monoxide
inhibition of the steroid 21-hydroxylation reaction in adrenal
cortex microsomes by observing the rate of hydroxylation of
17a,-hydroxyprogesterone under an atmosphere composed of
different carbon monoxide to oxygen ratios. The result was
expressed as a partition coefficients
for each ratio of the gases, where n is the ratio of hydroxy-
lation rate with carbon monoxide present to the uninhibited
rate, as defined by Warburg (19^9). The partition constant,
K, was found to vary between 0*6 and 1*8 for different pre¬
parations of adrenal microsomes. These values were found to
be similar to the partition constant for cytochrome P-ij.50
as determined by spectrophotometry titration. The value
of the partition constant for the carbon monoxide inhibition
of steroid 21-hydroxylation is quite different from the
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Photochemical action spectrum for the light-reversal of CO inhibition of
21-hydroxylation of 17a-hydroxyprogesterone. Incubations were gassed with a mixture of
4.4% O2 and 9.5% CO in nitrogen. The results are plotted in terms of relative light
sensitivity Lx/L452, versus wavelength of the light applied.
Pig. 1.2. Photochemical action spectrum for the light
reversal of the CO inhibition of the steroid
21-hydroxylase of bovine adrenocortical
microsomes. After Omura etal. (1965).
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which are 1*8 - 8*0 x 10~3 an£ about 10 - 20, respectively.
(Keilin and Wang, 19l|6).
These results suggested a role for cytochrome P-l+50
in steroid 21-hydroxylation. Use of the photochemical
action technique of Warburg (191+9) provided more conclusive
evidence that the carbon monoxide complex of cytochrome P-ij.50
is the carbon monoxide derivative of the terminal oxidase
of the hydroxylase system. The technique utilizes the fact
that the degree of dissociation of the GO complex of a
haemoprotein by monochromatic light of different wavelengths,
but equal intensities, corresponds to the light absorption
spectrum of the GO derivative of the reduced haemoprotein.
In the case of an hydroxylase system, the 1ight-indueed dis¬
sociation of the CO complex can be measured by the release of
the CO inhibition of the hydroxylation reaction. The photo¬
chemical action spectrum obtained for the steroid 21-hydroxylase
by Omura et al. (1965) is shown in Fig. 1.2. The similarity
to the Soret band of the GO complex of cytochrome P-iq.30 is
further evidence for the identity of adrenal microsomal cyto¬
chrome P-J+50 with the terminal oxidase of the steroid 21-
hydroxylase enzyme system.
The photochemical action spectrum technique has sub¬
sequently been employed to show a similar role for the
cytochrome P-I4.5O of adrenal cortex mitochondria in the
steroid 113-hydroxylase (Wilson et al. (1965); Rosenthal
and Cooper, 1967)* cholesterol side-chain cleavage enzyme
(Simpson and Boyd, 1967a) and the 18-hydroxylase systems
(Greengard et al., 1967), as well for several other steroid
7
hydroxylases and drug metabilizing systems of liver endo¬
plasmic reticulum (Voigt, 1968; Omura et al., 1965).
Thus, there is considerable evidence, that in the
adrenal cortex, cytochrome P-I4.5O is responsible for oxygen
activation in steroid mono-oxygenases, both mitochondrial
and microsomal.
Substrate binding by cytochrome P-l+50: Studies of the
adrenal cortex microsomal 21-hydroxylase system
(Narasimhulu, 1965) revealed that cytochrome P-I4.5O is
also the site of substrate binding. Addition of 17a-
hydroxyprogesterone to adrenal cortex microsomes in the
absence of NADPH, produced a change in the spectral properties
of the microsomal haemoprotein. The resultant difference
spectrum is characterised by the formation of an absorption
minimum at i|20 nm and a maximum at 390 nm. Addition of
NADPH to the system resulted in the gradual disappearance
of the spectral characteristics. The cyclic appearance and
disappearance of this absorbance change occurred on readdition
of the steroid substrate. Other mono-oxygenase systems such
as the llp-hydroxylation of DOC by adrenocortical mito¬
chondria and the induced drug hydroxylation system of liver
microsomes have been shown to produce similar substrate
binding spectra (Cooper et al«, 1965; Schenkman et al., 1967).
Titration of adrenocortical microsomes with 17a-hydroxy-
progesterone produced saturation of the binding sites at high
substrate concentrations (Narasimhulu et al., 1965), From
such data, an apparent substrate dissociation constant (K )s
was calculated and was found to be close to the K value
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(for the overall 21-hydroxylation reaction. However,
Estabrook et al. (1968) suggested that, since the substrate-
induced spectral change was not independent of the protein
concentration, the value of Kg obtained was not equivalent
to a true but rather was representative merely of stoichio¬
metric binding of the steroid to a reaction site associated
with the hydroxylation reaction.
Induction of spectral alterations in adrenal microsomes
or mitochondria have now been shown with the corticosteroid
intermediates, 20a-hydroxycholesterol, pregnenolone, 17a-
hydroxyprogesterone, deoxycorticosterone and 11-deoxycortisol
(see Harding et al.» 1969). The data of Gammer and Estabrook
(1967) suggest that it is the oxidised Fe^"1* form of cyto¬
chrome P-i4.50 that binds substrates, since cytochrome P-ij.50
in adrenocortical mitochondria is mainly in the oxidised
form under aerobic steady state conditions.
Forms of cytochrome P-li50» The specificity of the reactions
concerned in steroid biosynthesis and the existence of genetic
defects in humans involving the absence of one or other
hydroxylation activities (Eberlein and Bongiovanni, 1956)
predicts the existence of additional enzymes in the multi-
enzyme hydroxylating pathway or the existence of substrate
specific cytochrome P-I4.5OS.
The studies of Hildebrant et al. (1968) have indicated
the presence in liver microsomes of two interconvertible forms
of cytochrome P-[|_50 (named P-I4.5O and P-lji+6) which have
different absorption maxima in the oxidised state. One
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form (P-i^lj.6) is characteristic of a high spin type haerno-
protein, whilst the other (P-1^50) resembles a low-spin type
haemoprotein. Each of these forma is induced by one of two
classes of compound, typified by phenobarbital in the case of
P-I4.5O and 3-methylcholanth.rene in the case of P—JL4-JL4.6• Imai
and Sato (1968) also observed the presence of two spectrally
different states in the ethyl isocyanide complex of reduced
cytochrome P-J4.5O. Mitani and Horie (1969a) from studies on
adrenocortical mitochondria found that the absolute absorption
spectra of cytochrome P-J4.5O in the presence and absence of
substrates suggested that type I and type II - difference
spectra resulted from increases in the amount of high-spin and
low-spin components, respectively. The spectrum in the
absence of substrate was intermediary between the high and low-
spin types of spectrum.
Harding et al. (1969) have studied the effect of 20a-
hydroxycholesterol on the binding of deoxycorticosterone by
adrenocortical mitochondria. Their hypothesis which explains
the data requires that there be two specific P-I4.5OS in
adrenocortical mitochondria. TtypeIP-lj.50 binds 113-hydroxylation
substrates (i±20 nm, trough; 385 nm peak). The type II P-I4.5O
binds the 22R-hydro;xylation substrate but can bind other
steroids if they are present in high concentration.
Cytochrome P-k50 - EPR Spectrum. In addition to the optical
spectrum, cytochrome P-lj.50 is also characterised by its
electron paramagnetic resonance (EPR) spectrum. Addition
of steroid substrate produces a change in the EPR speotrum
as well as the optical spectrum (see Harding et al., 1969;
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Simpson et al., 1969i Mitani and Horie, 1969b). The EPR
signals obtained for adrenocortical mitochondrial cytochrome
P-I4.50 (Mitani and Horie, 1969b) correspond to those reported
by Hashimoto et al. (1962) for liver microsomal Fe_.
" A
Electron Transport System of Mono-oxygenases
In the classical mitochondrial respiratory chain, the
reaction of pyridine nucleotides with haemoproteins is
mediated via electron carriers such as flavoproteins, quinones
and non-haem iron proteins. Similarly, electron carriers are
involved in the supply of reducing equivalents from NADPH to
the cytochrome P-I4.5O. Omura et al. (1966) succeeded in
resolving the steroid lip-hydroxylase of adrenocortical
mitochondria into three fractions - a particulate fraction
containing cytochrome P-I4.50, a FAD-containing flavoprotein
and a non-haem iron protein which has been called 1adrenodoxin1
(Suzuki and Kimura, 1965).
The flavoprotein associated with the lip-hydroxylase
system has a molecular weight of about 60,000 and contains
FAD as its prosthetic group. This flavoprotein functions as
a diaphorase only when NADPH is an electron donor. (Omura
et al.» 1966). The combination of both flavoprotein and
non-haem iron protein is required for electron transfer from
NADPH to cytochrome 0.
The non-haem iron protein, adrenodoxin, has a molecular
weight of about 12,000 and contains 2 atoms of iron and 2
atoms of acid-labile sulphur per molecule (Kimura and
Suzuki, 1967). The absorption spectrum of the oxidised
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Fig. 1.3. Scheme of electron transport in microsomal
and mitochondrial mixed-function oxidases
of bovine adrenal oortex. After Simpson
et al. (1969).
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in the visible spectrum. The EPR spectrum of the reduced
form has a prominent signal at g = 1*9^., typical of many
non-haem iron proteins from both plant and animal ferredoxins
(Beinert and Sands, I960). A similar non-haem protein has
been purified from testis mitochondria (Kimura and Ohno, 1968)
which could substitute for adrenodoxin in adrenal steroid
110-hydroxylation. Rat ovarian mitochondria also contain a
protein with very similar properties (Kimura and Ohno, 1968;
Sulimovici and Boyd, 1968b). The biochemical aspects of
non-haem proteins such as adrenodoxin have been reviewed by
Kimura (1968) .
The flavoprotein and adrenodoxin constitute the NADPH-
cytochrome P-i^.50 reductase system. Combination of these
components with cytochrome P-I4.5O is required to restore 110-
hydroxylase activity.
The cholesterol side-chain cleavage system of adrenal
mitochondria has been resolved into the same three components
(Simpson and Boyd, 1967b; Bryson and Sweat, 1968). There is
the possibility of the presence of a fourth component
(Kimura, 1968) to determine the specificity of the particular
hydroxylation reaction since 18-hydroxylation also occurs in
adrenal cortex mitochondria (Greengard et al., 1967).
In microsomes, no EPR signal corresponding to the mito¬
chondrial non-haem iron protein signal has been detected.
Microsomal electron transport systems are less well understood,
though certainly a flavoprotein is involved (Sweat et al.
1969). Williams and Kamln (1962) isolated a flavoprotein







Pig. 1.4. Schematic representation of electron transport
in bovine adrenal cortex mitochondria, showing
the postulated role of energy-linked transhydro-
genase (ELTH) and succinate-linked reduction of
pyridine nucleotide (SLRPN) via reversible
eleotron transport. OAA,oxaloacetatej ME,
malic enzyme. After Caramer et al. (1968).
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Pig. 1.3 shows schemes for the microsomal and mito¬
chondrial mono-oxygenase electron transport pathways, as
far as they are understood at the moment.
Supply of Reducing Equivalents during Steroid Hydroxylation
The immediate source of reducing equivalents for steroid
mono-oxygenase reactions is NADPH. Presumably in the micro¬
somal systems, cytochrome P-J4.3O and the respiratory electron
transport pathway are in functional contact with the cyto¬
plasmic NADPH-generating systems such as glucose-6-phosphate
dehydrogenase. Mitochondrial hydroxylation activity is,
however, dependent upon the integrated action of the mito¬
chondrial dehydrogenases and also the respiratory chain as
shown in Pig. 1.1^. The ability of Krebs tricarboxylic acid
cycle intermediates to support the 113-hydroxylation of
deoxycorticosterone in adrenal cortex mitochondria has been
known for a considerable time (Kahnt and Wettstein, 1951J
Hayano and Dorfman, 1953J Brownie and Grant, 195i|) • Sweat
and Lipscomb*. (1955) suggested that the tricarboxylic cycle
intermediates supported 113-hydroxylation by reducing the
NADP+ to NADPH, possibly via a transhydrogenase. Grant
(1956) demonstrated the reduction of NADP+ in adrenal mito¬
chondrial acetone powders using fumarate as substrate.
Grant and Brownie (1955) suggested the involvement of 'malic
enzyme1 in the reduction of NADP+» since pyruvate was formed
during the oxidation of fumarate in the presence of NADP+.
The difficulty was that 'malic enzyme' was generally thought
to be exclusively a cytosol enzyme (Hsu and Lardy, 1967).
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However, Simpson and Estabrook (1968) demonstrated con¬
clusively the existence of a mitochondrial 'malic enzyme*
in bovine adrenal cortex. The NADPH required for steroid
113-hydroxylation could be accounted for by the activity of
this enzyme which catalyzes the reaction:
Mi*1" or Mr**" „
Malate + NADP Pyruvate + NADPH + C02
The biraodal distribution of the enzyme together with the
different kinetic properties of the mitochondrial and cytosol
enzymes led to the postulation of a 'malate shuttle* (Cammer
et al., 1968j Simpson and Estabrook, 1969) as a mechanism
of transferring reducing equivalents into the mitochondria.
Peron et al. (1966) and Guerra et al. (1966) using rat
adrenal mitochondria showed that succinate— and Malate—
supported 113-hydroxylation was inhibited by the respiratory
uncoupler,dinitrophenol. Harding et al. (1965)* again using
rat adrenal mitochondria, showed that antimycin A and cyanide
at concentrations which inhibited respiration, abolished
succinate-supported 113-hydroxylation. These results prompted
the suggestion that NADP* might be reduced by NADH via an
emergy-linked transhydrogenase and that reduction of NAD+by
succinate might occur via reversed electron transport in the
NADH dehydrogenase part of the respiratory chain.
Thus reducing equivalents for mitochondrial mono-
oxygenases arise from the action of mitochondrial dehydro¬
genases which transfer electrons from Krebs cycle intermediates
in part via an energy controlled nucleotide transhydrogenase
and in part by malate decarboxylation and reduction of
NADP* by the malic enzyme. This is illustrated in Pig. I.J4..
111.
Oxygen Utilization by Steroid Mono-oxygenases
Steroid mono-oxygenases by definition utilize molecular
oxygen. Very little is known about the nature of oxygen
activation and incorporation. It has been postulated that
the perferryl ion FedlJ-Og is the so-called active oxygen.
However Sih (1969) has suggested, since such complexes are
stable towards oxidation of unactivated carbon-hydrogen
bonds, that the active form is the hydroperoxo-complex of
ferrous ion [Fe(II)-0-0H]~, a much more reactive species.
Studies of Bray and co-workers (Knowles et al. 1969) have
shown the presence of 0~ in the xanthine oxidase-catalyzed
oxidation of xanthine - a mixed-function oxidation. However
mm •
it must be remembered that 0^ is one of the more stable
oxygen radicals. Gorey and Gregariott. (1959) suggested that
the species of active oxygen in the hydroxylating inter¬
mediate is in a positively charged electrophilic form such
as H0+. The existence of H0+ now appears unlikely (Samuel, 1968).
Staudinger (1966) presented evidence concerning the attacking
oxygen species and showed that hydroxylation may be mediated
by the generation of an oxygen atom rather than free hydroxyl
radicals. The oxygen atom () is regarded as a very
powerful oxidant, capable of cleaving G-H bonds directly.
Other speculations on the chemical nature of the active oxygen
intermediate have been made - reviewed by Diner (1964) - but
its true nature is still unknown.
Recent reviews on the nature of steroid hydroxy lations
and their associated enzymes include those by Simpson et al.
(1969) and Harding et al. (1969).
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THE CHOLESTEROL SIDE-CHAIN CLEAVAGE REACTION
Quantitatively the most important catabolic fate of
cholesterol in mammalian systems is its degradation to bile
acids - which occurs in the liver (Danielsson
et ai., 1963). However, a very important physiological
event is the degradation of cholesterol to produce steroid
hormones. This reaction which occurs in endocrine tissue
such as the adrenals, the gonads and the placenta, involves
the removal of a C^ unit from the alkyl side-chain of
cholesterol to produce the C2l steroid, pregnenolone (Staple
et al.» 1956). There are reports (Shimizu et al., 1965;
Jungman, 1968) that cholesterol can be converted directly to
dehydroepiandrosterone which involves the simultaneous
production of 2-methylheptan-6-one. Such a pathway would
allow the direct production of androgens without the inter¬
mediary formation of steroids. The relative importance
of such a pathway compared to the classical pathway of C-^g-
steroid biosynthesis, i.e. cholesterol —> pregnenolone —>
androgens, is not yet known.
Gurin and his collaborators (Lynn et al., 1954; Staple
et al., 1956) first demonstrated that a six-carbon fragmmt
is cleaved from cholesterol during the process by which the
sterol is converted to pregnenolone.
The enzyme system responsible for the cleavage of the
cholesterol side-chain between carbon atoms 20 and 22 has been
most studied in adrenal cortex and is located in the mito¬
chondria. Halkerston et al. (1961) using acetone powders of
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Fig. 1.5. The postulated pathways of the cholesterol
side-chain cleavage reaction in endocrine
tissue.
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molecular oxygen and NADPH and thus partially fulfilled the
requirement to be considered as a mixed-function oxidase
or mono-oxygenase.
The most commonly postulated pathway (Fig. 1.5) for
the conversion of cholesterol to pregnenolone in steroid-
hormone producing organs entails 20a-hydroxycholesterol and
20a,22R-dihydroxycholesterol as intermediates (Shimizu et al.,
1961; Constantopoulos and Tchen, 1961; Shimizu et al., 1962).
This hypothetical scheme was advanced on the basis that
(i) cholesterol is cleaved between carbons 20 and 22 giving
rise to a six-carbon fragment (Staple et al., 1956;
Constantopoulos et al., 1962), (ii) 20a-hydroxycholesterol is
formed from cholesterol-l|.-''"^C by cow adrenal cortex homogenates
in the presence of various trapping agents (Solomon et al.,
1956), and (iii) 20a-hydroxycholesterol and 20a,22R-dihydroxy-
cholesterol are more efficiently transformed to pregnenolone
than is cholesterol (Shimizu et al., 1961; Shimizu et al.,
1962).
The question of the transformation of cholesterol into
20a-hydroxycholesterol or 20a,22R-dihydroxycholesterol has
been controversial. Thus Solomon et al.(1956) claimed the
formation of 20a-hydroxycholesterol from cholesterol , under
certain trapping conditions, in the presence of 20a-hydroxy-
cholesterol;. Constantopoulos et al.(1962) described the
accumulation of 20a,22R-dihydroxycholesterol with a bovine
adrenocortical preparation in the presence of pregnenolone
and progesterone. Ichii et al. (1963) described the formation
of both sterols from cholesterol with bovine corpora lutea
when pregnenolone was added to the medium. On the other
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hand, Koritz and Hall (1961|), Hall and Koritz (1961;) and
Simpson and Boyd (1967a) were unable to observe the formation
of these sterols from cholesterol. Simpson and Boyd (1967a)
also cast doubt upon the significance that can be attributed
to the observation that 20a-hydroxycholesterol can inhibit the
side-chain cleavage of cholesterol, since 25-hydroxycholesterol,
26-hydroxycholesterol and, especially, 21^-hydroxycholesterol
also inhibited the cleavage. Furthermore, the mechanism of
inhibition produced by these hydroxylated cholesterol
derivatives was apparently the same as that produced by
20a-hydroxycholesterol, so that the inhibition evoked by the
latter compound could not be taken as evidence for its inter-
mediacy.
22R-Hydroxycholesterol has also been shown to give rise
to pregnenolone in bovine adrenocortical acetone-dried
mitochondrial preparations (Chaudhuri et al., 1962) in a
yield exceeding that realised from cholesterol, but this
alternative pathway has been largely ignored. However,
recently, Burstein and Gut (1969) have proposed 22R-hydroxy-
lation as the initial step in the cholesterol side-chain
cleavage reaction, since the
formation of 20a-hydroxycholesterol was considerably slower
than the formation of 22R-hydroxycholesterol. Furthermore,
the overall rate of disappearance of 22R-hydrocycholesterol
and the appearance (from it) of pregnenolone was relatively
much higher than that obtained with 20a-hydroxycholesterol.
The problem is further complicated by the observation
of Shimizu (1968) that the side-chain cleavage of 20a,22R-
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dihydroxycholesterol has a requirement for molecular oxygen
and NADPH, i.e. the cleavage of the dihydroxysterol is
apparently a mixed-function oxidation.
Prom these reports, it is clear that the question of
the identity of the intermediates between cholesterol and
pregnenolone remains unclear. The evidence presented for
the presence of these intermediates must be considered indirect
such as mobility on chromatograms and recrystallization
with authentic carrier. No-one has succeeded in isolating
any of the products in well-characterized crystalline form.
Involvement of cytochrome P-ii50 in the cholesterol side-chain
cleavage reaction
Simpson and Boyd (1966) demonstrated that the cholesterol
side-chain cleavage activity in adrenocortical mitochondrial
extracts was inhibited by carbon monoxide. Furthermore,
the partition constant for the carbon monoxide inhibition
was found to be about unity, and similar to the partition
constant of cytochrome P-I4.5O with carbon monoxide. In 1967*
Simpson and Boyd showed that the carbon monoxide inhibition
was light reversible, and the photochemical action spectrum
for the ligiht reversal showed a maximum at i|50 nm, similar
to the optical spectrum of cytochrome P-J4.5O (Omura et al.,
1965)# Thus cytochrome P-I4.5O appeared to be involved in the
cholesterol side-chain cleavage reaction in a similar
capacity (i.e. as the oxygen-activating site) as had been
reported for other steroid mixed-function oxidases (Estabrook
et al., 1963; Omura et al., 1963).
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Fractionation of the Cholesterol aide-chain cleavage
Enzyme System
Following the fractionation of the adrenal mitochondrial
steroid IIP-hydroxylase system into three components - cyto¬
chrome P-I4.5O, a flavoprotein and a non-haem iron protein -
(Ornura et al.« 1966), Simpson and Boyd (1967b) partially re¬
solved the adrenocortical mitochondrial cholesterol side-
chain cleavage system into the three similar components.
Thus the steroid 11g-hydroxylase and the cholesterol side-chain
cleavage enzyme system appeared to be very similar, substrate
specificity being determined by either separate cytochrome
P-i|50s or some other factor. Bryson and Sweat (1968)
confirmed the resolution of the adrenal cholesterol side-chain
cleavage system using an ammonium sulphate fractionation
technique. In 1968, Sulim<cnrii&t and Boyd (1968b) showed
that a similar three component system of NADPH diaphorase,
non-haem iron protein and cytochrome P-I4.50 was operative in
the case of the rat ovarian cholesterol side-chain cleavage
enzyme.
Precursor pool of cholesterol
Armstrong et al. (I96I4.), using rat ovarian slices,
observed that the specific activity of ^^"G-progesterone
biosynthesised from acetate-l-^C was higher than the
specific activity of the "^C-cholesterol in the same incubation.
The authors concluded that there was a lack of homogeneity
of the ovarian cholesterol pool, with only part of the total
sterol being drawn upon for steroid synthesis. The same
concept that the precursor cholesterol might be a small portion
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of the 'total cholesterol * in the adrenal gland had been
previously proposed by Hayano et al. (1956). The studies
of Koritz and Peron (1958) have also suggested that AGTH
makes a steroid precursor 'available' in rat adrenal gland.
Solod et al. (1966) proposed that in rabbit ovary the
cholesterol laid down most recently, whether derived from
plasma cholesterol or synthesised in situ from acetate, was
the first to be used for pregnenolone formation. When the
rate of steroid secretion is increased by luteinizing hormone
cholesterol deposited in the tissue at an earlier time is
available for pregnenolone synthesis. The precursor pool of
cholesterol for steroidogenesis might therefore be only a
small fraction of the total cholesterol within the tissue.
Such a situation appears feasible as cholesterol has an
important structural role in the lipoprotein complexes of .
the subcellular organelles, as well as the quantitatively
less important role as the steroid hormone precursor.
PLACENTAL STEROIDOGENESIS
Shortly after the isolation of pregnanediol from human
pregnancy urine (Marrian, 1929; Dingemanse et al., 1930),
it was realized that it is a major metabolite of
progesterone (Browne et al., 1937) and that its excretion
increased with progressing pregnancy (Venning, 1938). It
was soon apparent that large amounts of progesterone were
elaborated during pregnancy and that it was the placenta
which was the site of origin. Similar evidence led to the
conclusion that the large amounts of oestrogens elaborated
21
during pregnancy were also formed in the placenta. The
early evidence has been reviewed by Diczfalttsy and Troen
(1961).
Conversion of acetate to cholesterol has been demon¬
strated in both perfused placenta (Levltz et al., 1962) and
in placental tissue minces (Van Lettsden and Villee, 1965).
However, Villefe et al. (1966) have concluded that the rate of
cholesterol synthesis from mevalonate is much less than the
rate of progesterone production. In late pregnancy, the
placenta is capable of producing over 250 mg. of progesterone
per day (Pearlman, 1957). It is possible, therefore, that
the circulating plasma cholesterol (as lipoprotein) could act
as the precursor of progesterone. It is generally accepted
that the placenta is an "incomplete" endocrine organ that does
not synthesize complex steroids and sterols from acetate in
amounts sufficient to explain the large steroid output during
pregnancy. Preformed precursors of maternal and foetal
origin, such as dehydroepiandrosterone sulphate (siiteri and
MacDonaJ-d, 1963) and l6a-hydroxydehydroepiandrosterone sulphate
(Magendantz and Ryan, I96I4.) reach the placenta via the foetal
and maternal blood and are converted to oestradiol, oestrone
and oestriol by the placental aromatizing system. Placental
tissue contains very small amounts of steroid 17-20 lyase
(desmolase), as demonstrated by the conversion of progesterone
to androst-4-ene-3,17-dione (Little et al., 1963; Warren and
Cheatum, 196ij.) but the pathway appears insignificant. This
enzyme system is much more active in the foetal adrenal -
illustrating the function of the complete "foetal-placental
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unit".
The hydroxysteroid dehydrogenases occur in considerable
amounts in placental tissue. The most extensively studied
placental enzyme is probably the 173-oestradiol dehydrogenase.
This soluble enzyme has been studied principally by Engel
and collaborators (see Karavolas et al.f 1969) and Talalay
et al., 1958)* Considerable information is available about
the placental 33-hydroxysteroid dehydrogenase and the to
A^-isomerase system. The reaction is rapid (Pion et al.,
1966). Koide and Torres (1963) provide evidence that the
enzyme is present in both particulate fractions of the tissue,
mitochondria and microsomes.
Several steroid hydroxylases are present in placental
tissue and as far as is known require both NADPH and molecular
oxygen. The most important (quantitatively, at least) are
the mitochondrial cholesterol side-chain cleavage system
(described in the next section)and the microsomal aromatising
system.
The mechanisms involved in aromatization have not yet
been fully elucidated, but it is generally accepted that 19-
hydroxylation of a A^"-3-oxo-structure is an early step in
the procedure (wilcox and Engel, 1963). However, the enzyme
appears to be carbon monoxide insensitive (Meigs and Ryan,
1968) and therefore possibly does not involve cytochrome P-I450.
Recently Shaw et al. (1969) showed that the enzyme system was
also present in placental mitochondria, and provided an
interesting example of a bimodal distribution of a steroid
hydroxylase.
Pig. 1.6 Steroid biosynthesis occurring in the placenta
and in other endocrine tissues that produce
steroids. After McKems (1969).
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Hydroxylation of oestrone, oestradiol and oestriol at
G-2 catalyzed by a placental microsomal enzyme has been
described (Lucis, 1965; Fishman and Dixon, 1967).
Other placental steroid hydroxylation reactions have
been reviewed by Mitchell (1967) and Hagerman (1969).
Fig. 1.6 illustrates the pathways of steroidogenesis in
placental tissue, and compares these pathways with those known
to occur in adrenal and ovarian tissue.
The Placental Cholesterol Side-chain Cleavage Enzyme System
In 19^-5 s Bloch found that in late
pregnancy blood-borne deuteriated cholesterol was converted to
pregnanediol, presumably via progesterone. Placental
perfusion experiments (Solomon et al., 195h-» I960) indicated
that radioactive cholesterol was converted to progesterone.
Shimizu et al. (1961) demonstrated that 20a-hydroxycholesterol
was converted to progesterone using a placental homogenate.
However, an active cholesterol side-chain cleavage
enzyme system was not isolated from placental tissue until
1965 (Morrison et al., 1965). These workers found that, as in
the other endocrine tissues the enzyme was located in the
mitochondria. A so-called ,solubilizedl preparation of the
enzyme was obtained from acetone powder extracts of placental
mitochondria. Attempts reported in this study to fractionate
the enzyme system and identify the components were unsuccess¬
ful. Ryan et al. (1966) reported that native placental mito¬
chondria converted radioactive cholesterol to progesterone,
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with a small yield (0.6$). However, a net synthesis of progesterone
by placental mitochondria was observed.
In 1968, Meigs and Ryan showed the cholesterol side-chain cleavage
activity of placental mitochondrial acetone powders was inhibited by
carbon monoxide; this inhibition being light reversible. In the same
study, the presence of cytochrome P-h50 in both placental mitochondria
and microsomes was first reported, but at a much lower concentration
(about one tenth) than in adrenal cortex tissue.
Our knowledge of the placental cholesterol side-chain cleavage
systems is based on these few reports.
Aims of the present study
This study has been concerned with a particular sterol mono-
oxygenase - the cholesterol side-chain cleavage enzyme system of human
term placenta. The preceding pages show that by contrast with the mono-
oxygenases of other tissues, this enzyme has received less attention than
it deserves, especially when the importance of the placenta as a source
of metabolites of cholesterol is taken into consideration. Moreover,
the physiological circumstance of its rapid postpartum extrusion provides
an exceptional opportunity for the study of a normal human tissue. It
was hopedthat isolation and purification of the placental enzyme system
would allow comparison with the much studied adrenal cortex and ovarian




Human term placenta (taken immediately after delivery)
Membranes and major blood vessels removed: Hashed with 0.9% saline
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Resuspension in 0.154M KC1.
Centrifugation, 10,000g, 10
min. - repeated twice.
Mitochondrial suspension
Acetone powder preparation
Ultrasonication (20 kc/s, 15 min)
and/or Lyophilisation.
(All fractionation procedures carried out at 0-4°C.)




Preparation of Tissue and Isolation of Subcellular fractions
Human tem placentae were obtained after normal delivery
and placed on ice. The preparation of the tissue was
commenced within one hour of delivery. The membranes and
major blood vessels were removed. The tissue was washed
with either 0*25 M sucrose or 0*9^ sodium chloride solutions
in an attempt to remove as much of the blood as possible.
The washed tissue was then minced using a domestic meat
grinder. The minced tissue was then homogenised in 1 vol.
0*25 M sucrose for 2 minutes using a top drive Waring
Blender (MSE).
The homogenate was centrifuged at 600 x g. for 10
minutes to sediment the nuclei and cell debris. The super¬
natant was decanted and retained while the sediment was re-
homogenised in 1 vol. 0*25 M sucrose and centrifuged at
600 x g. for a further 10 minutes. The combined super¬
natant s were centrifuged at 10,000 x g. for 20 minutes to
sediment the mitochondria. The 10,000 x g. supernatant was
further centrifuged at 105,000 x g. for 60 minutes. 'The
mitochondrial fraction was suspended in 0*151+ M potassium
chloride and centrifuged at 10,000 x g. for 10 minutes. This
washing procedure was repeated twice. All the described
operations were carried out between 0 - 5°C* I1*16 subcellular
fractionation procedure is outlined in Pig. 2.1.
Bovine adrenal cortex mitochondria were prepared in a
similar manner to the placental mitochondria, except that the
tissue was homogenised in 2 vols. 0*25 M sucrose.
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Method of assay
An enzymic assay has to be reproducible, rapid,
sensitive and simple. Spectrophotometry and fluorometric
methods are generally the techniques of choice and such
methods are employed in the study of the enzymes involved in
steroidogenesis. In such cases the interpretation of the
results is complicated by the possibility that the steroids
determined colorimetrically could arise either from de novo
synthesis or from the release of preformed stored steroids.
In the case of the cholesterol side-chain cleavage reaction,
such methods are not useful because pregnenolone, the product
of the reaction, has no dominant chromophore either in the
visible or the ultra-violet region of the spectrum. The
problem is further complicated, particularly in the case of
the subcellular fractions, by the fact that the added
cholesterol substrate will be chemically indistinguishable
from the endogenous cholesterol and will equilibrate with it
to an unknown extent. For these reasons, it was decided to
use a radioactive method of assay, using [14.—"^* ] cholesterol
(Radiochemical Centre, Amersham) of high specific activity
(60 mc/mmole)• Methods of separating and quantitating
radioactive steroids were available in the laboratory. These
procedures had been developed for studies on the cholesterol
side-chain enzyme systems of bovine adrenal cortex and rat
ovarian mitochondria (Simpson and Boyd, 1967a; Sulimovici
and Boyd, 1968a).
The enzymic assay used in this study was based on the
conversion of added [14-^^C] cholesterol to radioactively
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labelled C2l steroids. Radioactive product formation over
a standard period of time was used as a measure of the
enzymic activity. The concentration of unesterified endo¬
genous cholesterol in native mitochondria was found to be about
300 jig. per incubation. Each incubation contained mito¬
chondria from approximately 18 g. wet weight placental tissue.
Similarly, approximately 10 pg. cholesterol per incubation was
found when a lyophilized mitochondrial extract preparation
was employed as the enzyme source, again derived from
approximately 18 g. wet weight tissue. The cholesterol
estimations were performed using the Liebermann-Burchard
reaction described later in this section. As it is difficult
to obtain conclusive evidence concerning the equilibration
of the added [I4.—^"^"C 3 cholesterol with the endogenous cholesterol
of the mitochondria, it was decided to calculate the enzymic
activity as the rate of conversion of the exogenous [i+- C]
cholesterol into C^i radioactive metabolites. Throughout
this work, the cholesterol side-chain cleavage activity is
expressed as the percentage conversion of [ij.-^^c] cholesterol
to radioactively labelled steroids.
The [i|.-^c] cholesterol was chromatographed by thin-
layer chromatography (TLC) on Silica-gel H (developing
solvent; di-isopropyl ether-petroleum spirit, B.Pt. ■, 60 - 80°G
- acetic acid, 70:30:2) to remove possible autoxidised
cholesterol contaminants. The region corresponding to a
standard cholesterol reference sample (Organon) was eluted
from the plate with redistilled acetone. Each batch of
[il-^c] cholesterol was "cleaned" in such a way immediately
before use.
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It is possible (see also pp. 10U-105) that the radioactive
technique described cannot be regarded as providing an accurate
estimate of the enzymic activity in all circumstances, but it was
felt that valuable comparative information would be obtainable by
its use in suitably designed experiments.
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INCUBATION PROCEDURE
1 hour at 37°C in the presence of:-
Solubilised enzyme fraction equivalent to 18 gin. wet
weight tissue.
0.02M phosphate buffer pH 7.4.





















TLC Scanning and liquid scintillation counting
Pig. 2.2. The
for
incubation and extraction procedures
the cholesterol side-chain cleavage assay.
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Incubation procedure
The various mitochondrial enzyme preparations
(equivalent originally to 20 mg. mitochondrial protein)
were incubated with lp-^C-cholesterol (0*1 pC) in the
presence of an NADPH generating system (5 pmol NADP+,
50 pmol glucose-6-phosphate, 1*0 i.u. of glueose-6-phosphate
dehydrogenase). The incubations were carried out in a total
volume of 5*0 ml. at 37°G in air, using 25 ml. Erlenmeyer
flasks and a Dubnoff incubator with constant shaking. The
incubation period varied from 15 - 60 minutes depending on
the activity of the particular enzyme preparation. Incubations
were commenced by the addition of the radioactive substrate
in 0*05 ml. acetone.
Extraction procedure
The incubations were terminated by the addition of
10 ml. methanol. The protein precipitate was centrifuged
down and re-extracted with 15 ml. boiling ethyl acetate.
15 ml. chloroform was added to the combined extracts and the
mixture centrifuged to separate the organic and aqueous phases.
On removal of the aqueous phase, the organic phase was taken
to dryness using a current of air on a warm water bath.
Figure 2.2 summarises the extraction procedure.
Separation using thin-layer chromatography
The residue was dissolved in 0*3 ml. chloroform and
transferred to a thin-layer plate (20 cm. x 5*2 cm.) coated
with silica gel H (Merck). This process was repeated three
times for each residue resulting in 95-98/a of the initial
CHOLESTEROL
Pig. 2.3. Thin-layer radiochromatograra showing the
substrate and products after incubation of
supernatant of a placental mitochondrial
sonicate with [L).--L4c] cholesterol and NADPH.
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radioactivity being transferred to the plate. Standard
non-radioactive steroids were also applied at the origin.
The thin-layer plates were developed in the solvent system,
di-isopropyl ether-petroleum spirit (60-80°C, b.pt.) - acetic
acid (70:30:2, v/v). The plates were developed twice in
the same direction in this solvent system. After chromato¬
graphy the standards were visualised by spraying with a l:lj.
dilution of the scintillation liquid (see next section) with
methanol and viewing under an ultraviolet lamp. The plates
were scanned in a gas flow thin-layer scanner (Ravenhill and
Janes, 1967)* Figure 2.3 shows a typical scan obtained on
such a scanner after incubation of a lyophilized placental
mitochondrial extract with [Ip-^c] cholesterol. The two
radioactive products had the same mobility as the standard
pregnenolone and progesterone. The solvent system also had the
advantage of separating the postulated intermediates of the
cholesterol side-chain cleavage reaction (namely, 20a,22R-
dihydroxy-cholesterol) from cholesterol and the C21 steroids
(Simpson and Boyd, 1967a).
Measurement of radioactivity
The regions on the TLC plates corresponding to the
radioactive and standard steroids were directly scraped into
liquid scintillation vials. The scintillation liquid
employed was I4. g./litre 2,5-diphenyloxazole (PPO) and 30mg./
litre l,Ij.-bis-(5-phenyl-oxazolyl-2)-benzene (P0P0P) in dry
toluene containing 5$ (v/v) methanol. 5«0 ml. scintillation
fluid was added to each vial and the radioactivity was
determined using a Packard Tri-carb Model 31^-EX liquid
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scintillation spectrometer. Under the conditions of
operation carbon-l^ was counted with an efficiency of 72%,
No quenching was observed. Mitton (1967)showed that addition
of silica gel to the counting vial did not affect the counting
efficiency.
Table 2.1 shows the recovery of radioactivity throughout
all the procedures for a typical incubation.
Assay for 33-hydroxysteroid dehydrogenase activity
The enzymio assay for the 30-hydroxysteroid dehydro¬
genase activity was based on the cholesterol side-chain
cleavage enzyme assay described in the earlier sections of
this ohapter. [ip-^C] pregnenolone (Radiochemical Centre,
Amersham) replaced the cholesterol as the substrate
and NAD (0*2 mM) was added as the co-enzyme in place of the
NADPH. The radioactive steroids were analysed and quantitated
as before except that the TLC development was carried out in
chloroform-ethyl acetate (80:20, v/v).
Protein determinations
Protein concentrations were determined routinely by
tiuret
the modified^method of Layne (1957). Determinations of
small protein concentrations were performed using the method
of Lowry et al. (1931). In both cases, bovine serum albumin
(Sigma, London) was used as the protein standard.
Estimation of haem iron
This was measured by a modification of the method of
Adler and George (1963). All glassware for the iron deter-
TABLE2.1
RECOVERYOPADIOACTIVITYDURINGTHSSAPROCEDURE
RadioactivityaddedsRadi irecov redPe centage cholesterolCo.p.m.)radioa tivity* recovered 200,090c.p.m.Inincubationflask* 1 Afterextractionlpllij-0*6 Afterspottingthextract9950* OnT.L.C.plate196,25798*0
TOTAL99*11
31
mlnationa were soaked overnight in strong hydrochloric acid
and washed thoroughly with distilled water before use. To
a 1*5 ml. aliquot,0*5 ml. concentrated hydrochloric acid
and 0*5 ml. 25$ trichloroacetic acid were added. After
standing for 10 minutes the samples were centrifuged. The
supernatant was analysed for non-haem iron (see next section)
and the precipitate was incubated for 30 minutes in a boiling
water bath with 0*1 ml. hydrogen peroxide and 0*1 ml. per¬
chloric acid. After cooling, 0*1 ml. 10$ aqueous hydroxyl-
amine hydrochloride was added and the samples were allowed
to stand for 5 minutes. Then 1 ml. pyridine and 0*1 ml.
bathophenanthroline sulphonate solution (1 mg./ml.) were
added to each sample. After 10 minutes the solutions were
read at 535 nm. using a Unicam S.P. 600 spectrophotometer.
The acid non-extractable iron was taken as a measure of haem
iron. The iron determinations were made quantitative using
a calibration curve constructed using a freshly prepared
ferrous ammonium sulphate solution.
Estimation of non-haem iron
This was measured by a modification of the method of
Massey (19571 The supernatant remaining
after the acid precipitation (see previous section) wad de¬
canted. To a 1*5 ml. aliquot of this fraction was added
1*0 ml. pyridine followed by 0*1 ml. ascorbic acid solution
(5 mg./ml.) and 0*1 ml. bathophenanthroline sulphonate
solution (1 mg./ml.). After standing for 10 minutes, the
solutions were read at 535 nm. using a Unicam S.P. 600
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spectrophotometer. The acid extractable iron was taken
as a measure of the non-haem iron.
Estimation of labile sulphide
The inorganic sulphide (labile sulphide) of the non-
haem iron protein was determined by an adaption of the method
of Fogo and Popowsky (191+9). The sample to be analysed (in
1*0 ml. of solution) was placed in 0*3 ml. of l+$ zinc acetate
in a tube 10 x 75 *»m»» and 0*05 ml. of 12$ sodium hydroxide
was added. The tubes were stoppered and 0*25 ml. of 0*5$
N, N-diraethylphenylenediamine hydrochloride and 0*05 ml. of
0*023 M ferric chloride (in 1*2 N HGl) were added to each
tube; the stopper was replaced on the tubes rapidly after
each addition. After 20 minutes, 0*85 ml. of water was
added to each tube and the absorbance was determined at 670
nm. Using such an assay system, Lovenberg et al. (1963)
found that 1 (imole of sodium sulphide gave an absorbance of
11*1+ at 670 nm. This extinction coefficient was used to
calculate the inorganic sulphide content. These workers
also found that cysteine,oxidised and reduced glutathione,
insulin and bovine serum albumin did not react in this test,
thus indicating that this method is specific for inorganic
sulphide.
Estimation of the cholesterol (non-esterified) content of
mitochondrial preparations
The cholesterol content of mitochondrial preparations
were estimated by the Liebermann-Burchardt reaction.
Ghloroform-methanol (2:1, v/v) extracts of the preparations
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were taken to dryness under a stream of nitrogen after
removal of the aqueous phase. Chloroform was used as the
solvent for the dried extract. Redistilled acetic anhydride
containing 5$ v/v. of concentrated sulphuric acid was prepared
in a flask immersed in an ice-bath and then allowed to warm
to room temperature at which point it was added to the
chloroform phase. The colour was developed at 25°C for 3°
minutes and the optical density of the solution estimated at
625 nm. using 1 cm. light path glass cells and a Unicam
S.P. 600 spectrophotometer. Suitable blank solutions and
solutions of known cholesterol content were run with each
group of estimations (Boyd, 1962).
The estimation of mitochondrial phospholipid
The method employed for mitochondrial phospholipid
determinations was based on that used by Scholan (1969) to
estimate microsomal phospholipid. Methanol (10 ml.) was
added to a suitable aliquot of the mitochondrial phospholipid
and the suspension refluxed. After centrifugation, chloro¬
form (20 ml.) was added to the supernatant followed by water
(7*5 ml.). The resultant system was allowed to undergo
surface dialysis overnight. Samples were taken from the
chloroform layer, evaporated to dryness and 60% perchloric
acid (2 ml.) added. The solution was digested until clear.
After cooling and diluting, 2*0 ml. of the amidol/sodium meta-
bisulphite reducing solution (1 g. amidol + 20 g. sodium
metabisulphite in 100 ml. water) followed by 1 ml. of 8%
*
ammonium molybdate solution. The solution was diluted to
15 ml. and the optical density recorded at 570 nm. after
* Allen, (l91+0).
3k
10 minutes# A calibration curve for phosphorus content
was prepared using potassium phosphate solutions. The
value for the inorganic phosphorus content was multiplied
by 25 in order to obtain the value for the phospholipid
content of the mitochondrial fraction.
CHAPTER 3
PRELIMINARY STUDIES ON THE CHOLESTEROL
SIDE-CHAIN CLEAVAGE ENZYME OF
HUMAN PLACENTA





PRELIMINARY STUDIES ON THE CHOLESTEROL SIDE-CHAIN CLEAVAGE
ENZYME SYSTEM OP NATIVE PLACENTAL MITOCHONDRIA
Distribution of the enzyme
Experiments were carried out to establish in which
cell fraction the cholesterol side-chain cleavage activity
of human term placenta was located. Incubations were set up,
as shown in Table 3«1» containing mitochondria or microsomes
equivalent to 18 g. wet weight placental tissue. Incubations
were performed at 37°G for 60 minutes. The results for
separate experiments are shown in Table 3.2. It was found
that the cholesterol side-chain cleavage activity was located
only in the mitochondrial fraction. These results are in
agreement with those obtained by Morrison et al. (1965). It
is also in accord with most results on the location of the
cholesterol side-chain cleavage activity in other endocrine
tissues (e.g. Halkerston et al. (1961), Hall and Koritz (1961*.)).
An electron microscopic examination (kindly performed
by the Dept. of Pathology, University of Edinburgh) of the
isolated so-called mitochondrial fraction confirmed the view
that the preparation was of mitochondrial origin (see Figure
3.1). However, many of the mitochondria appeared damaged by
the homogenisation procedure and the preparation did contain
some endoplasmic reticulum.
When native placental mitochondria (equivalent to 18 g.
wet weight tissue) were incubated with cholesterol
and the NADPH generating system using the standard assay
technique described in Chapter 2, the only radioactive meta¬






















All incubations were performed in a total
volume of 5-0 ml in the presence of 20 mM
phosphate buffer, pH
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at 37°C, the conversions of [ii-^c] cholesterol to progesterone
varied between Pregnenolone, the usually accepted
product of the cholesterol side-chain cleavage reaction was not
detected. This means that the mitochondrial preparation
contained an active 33-hydroxysteroid dehydrogenase-iso-
raerase system. This enzyme system is normally assumed to
be of microsomal origin. The electron-microscopic examination
revealed that there were contaminating microsomes present in
the mitochondrial preparation.
Sources of reducing power for the cholesterol side-chain
cleavage reaction in placental mitochondria
The immediate source of reducing power for the
cholesterol side-chain cleavage reaction in bovine adrenal
cortex is NADPH (Halkerston et al., 1961). This \a in accord
with the classification of the enzyme as a mixed-function oxi¬
dase (Mason, 1957) i.e. it has a requirement for reduced
pyridine nucleotide and molecular oxygen. It has been of
considerable interest to determine the source of the NADPH
required for mitochondrial steroid hydroxylation (see Simpson
et al.« 1969). Simpson and Estabrook (1969) have presented
evidence suggesting an important role for intramitochondrial
'malic enzyme' as a means of supplying NADPH. In
bovine adrenocortical mitochondria there is good corre¬
lation between corticosterone formation from 11-deoxycortico-
sterone (113-hydroxylation) and pyruvate formation
from malate. However, Peron and co-workers (1966)
who have studied the same problem in rat adrenocortical mito¬
chondria (i.e. 113-hydroxylation) suggest that the energy-
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linked NADH-NADP+ transhydrogenase is important in intra-
mitochondrial NADPH generation. A species difference could
explain these conclusions.
In the present study, various Krebs tricarboxylic acid
cycle intermediates were incubated separately with native
placental mitochondria in the absence of the NADPH generator
system. The results are summarised in Table 3.3. It is
seen that only succinate (5mM) and to a lesser extent, iso-
citrate could support the cholesterol side-chain cleavage
reaction. Malate and fumarate did not support the cleavage
reaction. It, therefore, seems unlikely that intramito-
chondrial NADPH generation in placental mitochondria proceeds
via 'malic enzyme* activity. This is in agreement with the
observation of Dr. E.R. Simpson (personal communication) that
placental mitochondria contain very little detectable *malic
enzyme* activity. Isocitrate presumably supports the cleavage
reaction via the mitochondrial NADP+-linked isocitrate dehydro¬
genase. It was of interest to observe that when succinate
was used to supply the NADPH reducing equivalents the
detected product of the incubation was pregnenolone and not
progesterone. This indicated that the endogenous NAD+ was
reduced in the presence of succinate and no oxidised NAD+
was available for the dehydrogenase reaction to convert
pregnenolone to progesterone. These results were indicative
of NADH-NADP+ energy-linked transhydrogenase activity coupled
with reverse electron flow from succinate to NAD+*
Table 3.ij. summarises the data obtained when amounts of
NADPH greater than that (1 mM) normally employed in the
TABLE3.3
CHOLESTEROLSIDE-CHAINLEAVAGEACTI ITYOFNATIVEPL CENTAMIT HO DRIAINT PRESENCEOPVARIOUSXIDISABLSUB TRATESAOS IBLOURCERE UCINGEQUIVALE T Additions (20mg.protein/ml.) None NADPHgeneratingsyst m Malate,5mM Succinate,5mM Fumarate,5 M Isocitrate,5mMPercentageonversionf[i^-"^c]cholester ln 60min.at37°Cto: "^^C-pregnenolone"^ o esterTota 0*1-23 1-08 79 0-25*7 6-61 07* 0-25'7 0-2i|*0k'
38
standard enzymic assay were used. Pregnenolone was found
to accumulate at the higher NADPH levels. The experimental
data appeared compatible with the presence of an NADPII-NAD+
transhydrogenase in the placental mitochondrial preparation,
which reduced the level of the endogenous NAD+. However,
even at the highest NADPH concentration used (I4. mM), progesterone
was produced in considerable amounts, which means that all
the endogenous NAD+ is not reduced.
It can be seen (from Table 3»U) that extramitochondrially
produced NADPH (produced by the generating astern) can be
utilized by the cholesterol side-chain cleavage enzyme
system. Since NADPH only penetrates the mitochondrial
membrane at a very slow rate, the enzymic activity is pre¬
sumably a reflection of the intactness, or rather lack of
intactness, of the mitochondrial preparation. The Waring
blendor method of homogenisation is not noted for the
preparation of 'good' i.e. intact, mitochondria. However,
the more usual homogenisation technique employing a teflon
pestle and a glass homogeniser vessel is not very useful
when dealing with placental tissue due to the considerable
amount of connective and vascular tissue present.
Identity of the products
After extraction of each incubation, the concentrated
extract was applied on to a TLC plate and the chromatopiate
developed in the di-isopropyl ether-petroleum spirit-acetic
acid (70:30:2) system. The three radioactive peaks obtained
on scanning the plates using the gas-flow TLG scanner corres¬
ponded to standards of progesterone, pregnenolone and
TABLE3.ii.
EFFECTOFNADPHNTHECHOLEST ROLSIDE-CHAINCL AVAGEACTI I YNATIVP CEN AL MITOCHONDRIA Percentageconversionf[!j.-"h3]ch les er l at37°Cfor60min.t : NADPH(mM)^C-Pregnenoloneo esterTotal 1-02 80-43*2 1-5k'95*110-0 2-06 54*911'k 2-57*1k'311'k NADPHgeneratorsystemus d.20mgitochondrialprotei /m .
Pig. 3.2. Gas-liquid radiochromatograms of metabolites.
(a) Standard non-radioactive pregnenolone
and radioactive product from incubation,
identified as pregnenolone.
(b) Standard non-radioactive progesterone and
radioactive product from incubation identified
as progesterone.
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cholesterol respectively. The radioactive material
corresponding to pregnenolone and progesterone also behaved
as these compounds in the solvent systems chloroform-ethyl
acetate (8:2, v/v) and benzene-ethyl acetate-acetone
(6:1:1, v/v).
Par further identification, the radioactive samples
eluded from the thin-layer plates were analysed by gas-liquid
chromatography (GLC). Gas-liquid chromatography was carried
90
out by means of a Pye Argon Gas Radiochromatograph with a Sr
detector. The glass column (125 cm. x 0*5 cm. internal
diameter) contained 3/ 0V-17 on Gas Chrom P (Applied Science
Laboratories, State College) prepared as described by Holmes
and Stack (1956). The column was pretreated for 2L\. hours at
250°C. Operation temperature was 230°C with the flash
heater at 260°C. The argon flow rate was lj.0 ml./min. Gas
flow through the stream splitter and to the mass detector
was adjusted so that about 95/ of the sample went to the
radioactive detector and 5/ went to the mass detector.
Samples were introduced on to the column using a solid in¬
jector system (Menini et al., 1965).
The retention times (t^) of the substances injected
in relation to cholesterol (internal standard t^, = 15 minutes)
were identical with the relative retention times of standard
pregnenolone (050) and progesterone (0*75)* The radioactive
and mass detector traces are shown in Pig. 3*2.
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(B)
SOLUBILI SAT ION OP THE PLACENTAL MITOCHONDRIAL CHOLESTEROL
SIDE-CHAIN CLEAVAGE SYSTEM
As one of the primary aims of this work was to study
the cholesterol side-chain cleavage enzyme system from a
mechanistic standpoint rather than in relation to the cell
as a whole, methods of solubilising the enzyme system were
examined. Solubility in this study is defined in a strictly
operational manner i.e. presence of enzymic activity in a
105,000 g. x 60 min. supernatant. Because of the particulate
nature of at least one of the enzyme components (cytochrome
P-450), prolonged centrifugation at 105,000 g. will un¬
doubtedly sediment most of the component (see Cooper et al.,
1965)» However, the so-called 'soluble1 preparation does
permit some preliminary fractionation studies to be performed,
and so in that sense, it might be considered 'soluble'.
(a) Ultrasonicatlon
Cooper et al. (1965) observed that when a sonicate of
adrenal cortex mitochondria was centrifuged at 105,000 g. x
30 mins., steroid 110-hydroxylase activity was found in the
supernatant, although a large proportion of the activity was
still associated with the particulate material. Simpson and
Boyd (1966), using a similar procedure to Cooper, reported
that cholesterol side-chain cleavage activity could be found
in the 105*000 g. x 30 min. supernatant of a sonicate of
bovine adrenocortical mitochondria.
The preparation of ultrasonicated placental mitochondria
followed the method of these authors. The mitochondrial
pellet was resuspended by gentle hand homogenisation in
2 volumes of ice-cold distilled water. The suspension was
subjected to ultrasonication (20 kc/s) for 3 periods of
3 minutes duration with intervals for cooling, using a M.S.E.
Ultrasonic Disintegrator. The suspension was cooled in ice
throughout the sonication process. when this sonicate was
centrifuged at 103,000 g. for 30 minutes, and the supernatant
and the pellet assayed for cholesterol side-cnain cleavage
activity, the results shown in Table 3.5 were obtained.
The data showed that the cholesterol side-chain cleavage
activity resided in the supernatant of the placental mito¬
chondrial sonicate. It was seen that the sonicate pellet
had no activity and that when combined with the supernatant
resulted in an almost complete inhibition of the enzymic
activity. It was also noted that the activity of the mito¬
chondrial sonicate was less than the activity of the native
mitochondrial preparation.(from equivalent amounts of wet
weight tissue). This was in contrast to the effect of ultra
sonication on the bovine adrenocortical and rat ovarian mito¬
chondrial cholesterol side-chain cleavage enzyme systems
(Simpson and Boyd, 1967a; Sulimovici and Boyd, 1965b).
In both these cases, sonication of the native mitochondrial
preparations resulted in a considerable enhancement of the
cholesterol side-chain cleavage activity. It was apparent
that there was material present in the 103*000 g. sonicated
mitochondrial pellet that was inhibitory to the enzyme system
However, this Inhibition could be released merely by high
speed centrifugation of the sonicate (103,000 g., i+3 min.) to
TABLE3.5
THECHOLESTEROLSIDE-CHAINLEAVAGEACTI ITYOPNA IPLAC NT LMI OC ONDRIA, MITOCHONDRIALS NICATEA105,000g.x45I .SUPERNAT NTOFTHEMITOCHONDRIALSONIC TE EnzymeSource NativeMitochondria(20) Mitochondrialsonicate(20) 105,000g.x45min.supernatant(s^) ofsonicate(13) 105,000g.x45min.pellet(P,) ofsonicate(7) Si+PxPercentageconversionf[4-*^c]chol sterol in60min.at37°Cto: ^C-Pregnenolone-Progestero eT tal o*4 0-2 13*2 o-4 0-9
4*4 2-5 6*7 4-0 3-8
4*8 2-7 19*9 4*4 4*7
Proteinc ncentrations(mg.pro ein/ml.)arecordedinp ren hes s
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produce a supernatant which possessed enhanced cholesterol
side-chain cleavage activity (2-3 fold that of native mito¬
chondria). These results indicated '■*' T- that the
placental mitochondrial cholesterol side-chain cleavage
enzyme could be 'solubilised" and secondly, that material
inhibitory to the enzyme activity was associated with the
particulate fraction after sonication.
(b) Ultrasonication and Lyophilization
Sulimovici (1968) used various methods (ultrasonication,
acetone powder preparation, lyophilization, freezing and
thawing, detergents, etc.) in an attempt to solubilise the
cholesterol side-chain cleavage enzyme system present in
immature rat ovarian mitochondria. This author observed that
only when a combination of ultrasonication and lyophilization
was used could solubilisation of the enzyme be achieved.
A placental mitochondrial preparation suspended in 2
volumes distilled water was sonicated (as described in the
previous section) and the sonicate then lyophilized. The
lyophilized mitochondria were taken up in O'lM KCl (30 mg.
lyophilized material per ml. of solution) using hand homo-
genisation. The suspension was centrifuged at 103,000 g.
for 30 ruins. The resulting supernatant and pellet fractions
were assayed for cholesterol side-chain cleavage activity
using the normal assay technique. The results obtained are
tabulated in Table 3*6. Cholesterol side-chain cleavage
activity was only found .in the supernatant fraction. The
pellet material inhibited the cholesterol side-chain cleavage
activity of the supernatant very strongly. On an equivalent
TABLE3.6
THECHOLESTEROLSIDE-CHAINCLEAVAGACTIVI YOPLYOP IZEDP ENTALMIT H NDRI , THE105,000g.x6MIN.SUPERNATANTANDPELLETOPTHLYOPHILIZP CE TAL MITOCHONDRIALSUSPENSION EnzymeSourc Nativemitochondria(21) 30mg.lyophilizedmitochondrial suspension(15) jj{ 105,000g.x6rain,supernatant (S-^)oflyophilizedmitochondria(I4.) 105,000g.x6rain,pellet*(P^)of lyophilizedmitochondria(II) h+piPercentageconversionof[ij.-r*C] cholesterolin60min.at37Cto: ^^C-Pregnenolone^C-Prog st roneTotal O'k 0-3 15*1 o-i 0*6
k'k 0*9
It-*6 0-2 0-5
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Pig* 3*3* Time course of the formation of [^C]
pregnenolone and [^c] progesterone from
[i^~ ^"G ] cholesterol by a supernatant of
lyophilized placental mitochondria.
wet weight tissue basis, the lyophilized supernatant was
more active chan the sonicated supernatant preparation
(compare Tables 3*5 and. 3.6). This probably reflected
further extraction of the enzyme from the particulate phase
- where its presence could not be demonstrated due to the
presence of inhibitory material. A combination of ultra-
sonicaoion and lyophilization facilitated solubilisation of
the enzyme. It was observed after such a treatment that; the
particulate material was inhibitory towards cholesterol side-
chain cleavage activity. Figure 3.3 shows a time course of
the product formation when the lyophilized mitochondrial
supernatant was incuba&ed with [ip-'^c] cholesterol and the
HADPfl-generator system. The rate of product formation appeared
linear over a 60 minutes incubation period.
The lyophilized mitochondria could be stored several
weeks at -20°G with very little loss of activity. 500 gm.
of placental tissue on average yielded from 0'8 - 1*2 g. of
lyophilized mitochondria.
(c) Acetone powder preparation
Treatment of cellular and subcellular fractions with
acetone at around -20°C has commonly been used in attempts to
solubilise membrane-bound enzyme systems. It also has the
advantage of depleting the endogenous substrate(s) present
especially when these are of a lipid nature.
Halkerston et al. (1961) reported the solubilisation of
the cholesterol side-chain cleavage enzyme from an acetone
powder of bovine adrenocortical mitochondria. The activity
in the acetone-dried fraction could be solubilised by
kk
extraction with 0*067 M phosphate buffer pH 6*8, followed
by removal of particulate material by centrifuging at
105*000 g. for 60 minutes.
In the present study, washed mitochondrial suspensions
(in 2 volumes distilled water) were added dropwise to
20 volumes of acetone (at -I|.0oC) with continuous stirring.
Filtration was carried out using a Buchner apparatus. The
acetone-precipitated material was washed with 3 volumes of
acetone (at -20°G) followed by 3 volumes of ether (at -20°0)
Acetone and ether were stored during the operation in an
acetone-solid carbon dioxide (Cardice) bath. The material
was finally dried in a vacuum desiccator. One placenta
(approx. lj.00 g. tissue) yielded on average 1-T2g. mito¬
chondrial acetone powder.
300 mg. placental mitochondrial acetone powder were
suspended in 10 ml. 0*1 M KC1 using hand homogenisation.
The suspension was centrifuged at 105,000 x g. for 60 min.
When the resulting supernatant and pellet were assayed for
the presence of the cholesterol side-chain cleavage enzyme,
activity was found only in the supernatant. The pellet
material was inhibitory towards activity. The results are
shown in Table 3.7« The activity of the mitochondrial
acetone powder extract was observed to be three or four fold
that of the lyophilized preparation. Presumably at least
part of this enhancement was due to removal of endogenous
cholesterol substrate present in the mitochondrial preparation.
As with the sonicated and the lyophilized preparations,
the particulate material was found to be inhibitory towards
TABLE3.7














cholesterol side-chain cleavage activity.
Of the three methods of "solubilisation" investigated
(i.e. presence of activity in a 105*000 x g, 30 min.
supernatant), all were successful in obtaining a 'solubilised*
enzyme preparation. The enzyme appeared more readily
extractable than the enzyme of rat ovarian mitochondria
(Sulimovici, 1968). However, it was apparent in all three
cases that there was inhibitory material associated with the
insoluble mitochondrial particles. The presence of the
inhibitory substance was only made apparent when the native
mitochondria were subjected to some disruptive procedure,
since native mitochondria were enzymatically more active
than, for example, the mitochondrial sonicate. (compare
Tables 3.2 and 3.5) •
The next section will deal with investigations into
the nature and characteristics of this inhibitory substance.
Effect of time of high speed centrifugation
on the cholesterol side-chain cleavage
activity of the supernatant of a lyophilized
placental mitochondrial suspension.
at 105,000 xg
3.I4.. Effect of time of high, speed centrifugation
on the cholesterol side-chain cleavage activity




NATURE OF THE ENDOGENOUS INHIBITOR
It was apparent from the results of the attempts to
solubilise the placental cholesterol side-chain cleavage
system that there was, associated with the mitochondrial pre¬
paration, material that was inhibitory towards the cholesterol
side-chain cleavage activity. The inhibitory property was
only observed when the mitochondria were disrupted in some
way, e.g., ultrasonication or lyophilization. It appeared
that in the intact mitochondrion, the components of the enzyme
system (including here the substrate and the cofactor(s))
were protected from the inhibitor, presumably by the ordered
structure of the organelle. It was found that by means of a
purely physical technique, ultracentrifugation, the enzyme
could be separated from the inhibitor (see Table 3.5)*
Figure 3.J4. shows the time course of the sedimentation of the
inhibitor at 103,000 x g. from a suspension of lyophilized
placental mitochondria. This was achieved by taking an aliquot
of the supernatant at a given time, the remainder of the
supernatant being further oentrifuged to obtain the next
aliquot. It was found that maximal activity was not achieved
until after at least 90 mins. cBntrifugation at 103,000 x g.
Thus the inhibitory component must be associated with
particulate material of wide size range. After a plateau
region of activity, this then began to decrease. This pre¬
sumably could be due to partial sedimentation of a component (s)
of the enzyme system - possibly the cytochrome P-I4.5O as
reported by Cooper et al. (1963).
Effect of chloroform -methanol |2:1,v/v) extract of pellet on the
cholesterol side-chain cleavage of the 105,000g x 60min. supernatant











Chloroform-Methanol Extract of Pellet (ml)
(1ml Equivalent to 15mg Lyophilized Mitochondria)
Pig. 3.5* Effect of chloroform-methanol extract of
mitochondrial pellet on the cholesterol side-
chain cleavage activity of the 105,000 g x 60 min-
supernatant of lyophilized placental mitochondria
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Effect of heating
The inhibitory activity was still maintained after
heating the pellet suspension (in distilled water) for
15 min. in a boiling water bath. It was als.o, after this
treatment, still firmly associated with the particulate
fraction. The results are summarised in Table 3.8.
Extraction of pellet with ohloroform-methanol (2:1, v/v)
The evidence suggested the inhibitor to be.of lipoidal
character. The 105*000 x g. pellet of lyophilized mitochondria
was resuspended in 20 vols, chloroform-methanol (2:1 v/v) and
refluxed for 60 min. in an atmosphere of nitrogen. After
centrifugation (10,000 x g, 10 mins.) of this suspension,
inhibitory activity was found in the organic extract (see
Pig» 3*5)• This confirmed that the inhibitor was of lipid
origin.
Thin-layer chromatography of the chloroform-methanol
extract on silica gel H TLC plates developing the plates in
the system hexane-diethyl ether-acetic acid (75s2lj.:l, v/v),
showed that the detectable components of the extract consisted
of cholesterol, phospholipids and cholesterol esters. Detection
xvas accomplished either by spraying with phosphomolybdate or
by immersion in an iodine atmosphere. Samples of standard
phospholipid (remained at origin), Cholesterol (Rf, 0*10),
triglyceride (0• I4.O), cholesterol ester (0*95)» were run on
the same plate.
Each of the three components (together with a control
area of silica gel from behind the origin) was extracted
from the plates with chloroforra-methanol (2:1, v/v) and after
TABLE3.8
EFFECTOFHEATED(95° ,15MIN.)0 ,000g.x6IN.P LLETLYOPHI IZ DPLACE TAL MITOCHONDRIAOT ECH LEST OLSIDE-CHA NCL AVAGEACTI ITYF105,000g.x6 . SUPERNATANTOFTHELYOPHILIZEDMITOC ONDRIALPRE ARATION.H TLSUSPE S WASCPNTRIFUGEDATlOOOg.x15MIN PercentageConversionf[k-^C]cholesterol for60min.at37Ct : ^C-Pregnenolone^^C-ProgesteronTotal 105,000g.x6min.supernatant(S-^)9*2 31*3 Si+upernatantofheatedelle suspension11*70*62 3 S-,+Pelletofheat dpelle suspension2*70 63 3 Allpreparationswereresentinamou tequiva e tto30g.lyo hilizedmitochondria
Thin layer chromatogram of chloroform-methanol


















Cholesterol side-chain cleavage activity on addition
of chromatographed fractions.
Pig. 3.6. The inhibition of cholesterol side-chain
cleavage activity by eluted fractions after
TLG of the CHCl^-MeOH extract of the lyophilized
mitochondrial pellet.
kQ
removal of solvent each fraction was assayed for inhibitory
activity. The most inhibitory component was found to be
the origin (phospholipid) fraction (see Table 3.9). Each
assay was carried out with amounts of each fraction equivalent
to 30 mg. mitochondrial powder.
The phospholipid fraction was further resolved by TLC
using the development system, chloroform-methanol-water
(63s35s8# v/v) using basic silica gel H plates as described
by Skipski et al, (1962). Figure 3.6 shows the resolution
of the phospholipid fraction into two main components -
lecithin and phosphatidyl ethanolamine. There was also
apparently cardiolipin present in the neutral lipid fraction
at the solvent front, as well as smaller amounts of other
unidentified components. Each fraction was eluted from the
silica gel with chloroform-methanol (2:1, v/v). After re¬
moval of the solvent, each fraction (equivalent to 3 mg.
mitochondrial powder) was assayed for inhibitory activity in
the standard cholesterol side-chain cleavage enzymic assay,
using supernatant from a lyophilized mitochondrial preparation
as the enzyme source. The results are shown in Fig. 36..
It was observed that although most of the fractions showed
inhibitory activity, the most potent inhibitor was the
lecithin fraction. Qualitatively, the amounts of lecithin
and phosphatidyl ethanolamine were approximately equal with
smaller amounts of cardiolipin. Fleischer et al. (196?)
analysed highly purified mitochondria from bovine heart and
kidney and found them to contain diphosphatidyl glycerol
(cardiolipin), phosphatidyl ethanolamine and lecithin as major
Mpid components approximately in the molecular ratio l:^:^..
TABLE3.9
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Further investigation of acetone treatment of placental
mitochondria
It is well known that acetone treatment of mitochondria
results in a depletion of mitochondrial lipid - more than
90$ of which is phospholipid (Rouser et al., 1968).
Since
the phospholipid of placental mitochondria appeared to be
involved in the inhibition of cholesterol side-chain cleavage
activity on disruption of the mitochondria, it was decided
to re-investigate the acetone treatment of placental mito¬
chondria.
Placental mitochondria prepared using the normal pro¬
cedure were resuspended in 2 volumes distilled water and
added dropwise into 20 volumes of acetone (at -20°C) with
continuous stirring. Slow stirring was continued for 10
minutes during which time the temperature rose to about -5°C.
The resulting material was filtered using a Buchner apparatus.
The precipitated material was finally washed with 3 volumes
ice-cold ether before drying in a vacuum desiccator. Uien
this acetone-dried mitochondrial powder was assayed for
cholesterol side-chain cleavage activity in the normal manner,
i.e. suspension of the powder (30 mg./ml.) in 0*1 M KCl,
followed by centrifugation at 103,000 x g. for 60 min, the
105,000g. pellet did not inhibit the enzymio activity of the
supernatant. The results are summarised in Table 3*10*
The results also demonstrate that there is very considerable
steroid 33-hydroxysteroid dehydrogenase-isomerase activity
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associated with the pellet fraction since in the presence
of the pellet fraction progesterone was virtually the sole
product. It was also observed that there was very little
increase in the total cholesterol side-chain cleavage
activity on addition of the pellet, suggesting that almost
all the cholesterol side-chain cleavage enzyme was 1solubilised1.
This is in marked contrast to the solubilisation studies on
the steroid 113-hydroxylase of bovine adrenocortical mito¬
chondria when most of the 113-hydroxylase activity was still
associated with the particulate fraction (Cooper et al«,
1965). It therefore appeared that the inhibitory substance
was removed in the acetone filtrate. The acetone-ether
filtrate was dried over anhydrous Na2S0^ and then concentrated
to dryness on a rotary evaporator. The residue was dissolved
in chloroform-methanol (2j1 v/v) and assayed for inhibitory
activity. The solvent was removed prior to the addition of
the other components of the assay system. The results are
shown in Table 3.11. The filtrate thus contained the
inhibitory substance. Examination of the filtrate by TLC
using the solvent system hexane-diethyl ether-acetic acid
(75s2i|.:l, v/v) revealed two detectable components - phospho¬
lipid and cholesterol. Elution of the origin region (phospho¬
lipid) with CHCl^-MeOH (2:1, v/v) and redevelopment in the
chloroform-methanol-water (65:35:8) system (using basic
silica gel H plates - prepared using 0*01 M Na2C0^) revealed
two main phospholipid components - lecithin and phosphatidyl
ethanolamine, which ehromatographed with their respective
standards - together with a smaller amount of a component
TABLE3.11
















present at the solvent front - probably cardiollpin.
Addition of 5$ n-butanol to the acetone (at -20°C)
was also found to facilitate removal of the inhibitory lipid
from the mitochondrial preparations. It was, however,
difficult to remove the butanol, due to its relatively high
boiling point, to yield a dry mitochondrial powder.
It was apparent that phospholipid and possibly cholesterol
were involved in the inhibitory process. To attempt to
eliminate the involvement of cholesterol, the effect of
exogenous cholesterol on the cholesterol side-chain cleavage
activity of a supernatant of a mitochondrial acetone powder
suspension was Investigated.
Effect of cholesterol
Due to the nature of the standard cholesterol side-chain
cleavage assay - using tracer -cholesterol - it was
possible that at least part of the inhibition could arise from
dilution of the tracer by the endogenous cholesterol.
Cholesterol side-chain cleavage assays were therefore performed
in the presence of varying amounts of exogenously added 'cold*
cholesterol. This cholesterol was added in a small volume
(0*05 ml. acetone) with the tracer [i^-^C ] cholesterol (assumed
to have negligible mass). The results are summarised in
Table 3.12. The cholesterol content of a lyophilized mito¬
chondrial preparation was estimated to be about 300 ^g. per
30 mg. mitochondrial powder, using the Liebermann-Burchard
reaction (see Chapter 2). It was, therefore, apparent that
the endogenous cholesterol could not alone account for the
inhibition. It must, however, be remembered that the endogenous
TABLE3.12
EFFECTOFEXOGENOUSCHOL STEROLTHECHOLESTEROLSID -CHAINC AV GEAC IV TY OFTHE105,000g.x6M3N.SUPERNATANTOFmg.LYOPHILIZEDPLACE ALMITOCHONDRIAL SUSPENSION Amountfcholesteroladd d to5ml.incubation(ng) 20 50 200 14,00Percentageonversionf[1^-^^C]chol sterol to"^C-pregnenoloneluslf*0-proge t rone
22j.-6 23-0 17*9 13'k
Pig* 3*7. A Lineweaver-Burk plot showing the effect of
added cholesterol (s) on the cholesterol side-
chain cleavage activity of a supernatant of
lyophilized placental mitochondria
(v = percentage conversion).
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cholesterol is presumably mitochondrial lipoprotein
cholesterol, while the nature of the added cholesterol
would be presumably 'free* cholesterol.
The data was also used to calculate the apparent
Michaelis constant, K^, for the enzyme and the cholesterol
substrate. Figure 3.7 shows a Lineweaver-Burk plot
(Lineweaver and Burk, 1931+). The was found to be about
200 |xM, which is very high indeed. However, it must be
remembered that the enzyme source was a mitochondrial acetone
powder and so would be depleted in cholesterol. It seems
very likely that on readdition of cholesterol, it is bound
to sites not involved in the cholesterol side-chain cleavage
activity. Using a supernatant from lyophilized mito¬
chondria as the source of the enzyme, the was found in
some cases to be in the region of 1+0-60 jiM. However there
was considerable variation from one preparation to another.
The lower Michaelis constants for lyophilized mitochondrial
preparations presumably reflects endogenous cholesterol
binding to the cholesterol binding sites. Until the problems
of equilibration between added cholesterol and the cholesterol
binding sites, both structural and enzymic and the state of
cholesterol in mitochondrial lipoproteins are understood, a
will not be meaningful.
This was further evidence for the involvement of phospho¬
lipid in the inhibitory process. It was therefore decided
to investigate the effect of authentic highly purified
phospholipid.
Effect of phospholipids on cholesterol
side-chain cleavage activity.
Phospholipid (mg/ml)
Pig. 3.8. The effect of authentic phosphatidyl
ethanolanine and lecithin on the cholesterol
side-chain cleavage activity of a supernatant
(105*000 g. x 60 min.) of placental mito¬
chondrial acetone powder.
(v = percentage conversion)
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Effect of authentic phospholipid
Authentic samples of lecithin and phosphatidyl
ethanolamine were obtained from Lipid Products (Epsom).
Both phospholipid samples were obtained dissolved in hexane.
They were both colourless solutions - a good visual criterion
for the purity of phospholipid samples. The purities of the
samples were checked by thin-layer chromatography using the
development system chloroform-methanol-water (63:35:8) and
deactivated (0*01 M Na2G0^) silica gel H chromatoplates.
Both samples gave single spots - visualisation was by
immersion in an iodine atmosphere.
The hexane solvent was removed in a current of nitrogen.
The phospholipid residue was weighed and then suspended in
distilled water by means of ultrasonication (20 Kc/s, 10 sec.).
This procedure was found to produce a very good dispersion
of the phospholipid in water. The effect of varying amounts
of the particular phospholipid upon the cholesterol side-chain
cleavage activity of a 103*000 g. x 60 min. 0*1 M KOl extract
of o placental mitochondrial acetone powder was investigated
using the standard assay procedure. The results are shown
in Pig. 3.8. plotted according to Dixon (1933) • It was
observed that lecithin was a potent ishibitor of cholesterol
side-chain cleavage activity. However, phosphatidyl
ethanolamine at low concentrations (0*1 - O'ij. mg./inl.)
stimulated the enzymlc activity, but at higher concentrations
inhibition was observed (60% inhibition at 2 mg./ml.). Since
the actual substrate (cholesterol) concentration could not be
determined due to the probable presence of several binding
Effect of "105,000x60 min - pellet"on the cholesterol side-
chain cleavage activity of the 105,000x60 min. supernatant
(equivalent to 30mg lyophilized placental mitochondria.)
(1ml Equivalent to 15mg Lyophilized mitochondria)
Fig. 3.9a. Effect of varying amounts of lyophilized
placental mitochondrial pellet (103*000 g. x
60 min.) on the cholesterol side-chain cleavage
activity of the supernatant of lyophilized
mitochondria.
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sites for cholesterol, no attempt was made to calculate
an inhibitor constant, K^, for the inhibition.
Effect of varying amounts of the 105,000 g, pellet of
extracted lyophllized mitochondria
30-14.0$ of the dry weight of mitochondria is lipid, of
which about 95$ is phospholipid (see Rouser et al., 1968).
The effect of varying amounts of the 105*000 g. x 60 min.
pellet from a lyophilized mitochondrial suspension on the
cholesterol side-chain cleavage activity of the supernatant
was investigated to determine whether there was correlation
between the inhibition produced by endogenous phospholipid
in the pellet and the authentic phospholipids. The results
are shown in Pig. 3.9a. The data of Pig. 3.9a was replotted
according to Dixon (1953) as shown in Pig. 3*9b. Comparison
of Pigs. 3.8 and 3.9bdtiow that the pellet is a stronger
inhibitor of the enzymic activity than is the pure phospho¬
lipid. 50$ inhibition was observed when a pellet suspension
equivalent to 0*3 mg./ml. lyophilized mitochondria was present
i.e. about Ol mg./ml. phospholipid. The amount of lecithin
required for 50$ inhibition was O'i; mg./ml. It seems likely,
therefore, that phospholipid, especially lecithin, is closely
involved in the inhibitory process and that the state of
phospholipid is probably important. It must be remembered
that the purified lecithin was added as a dispersion in water
whereas the endogenous phospholipid of the mitochondria was
in a lipoprotein-type structure.
Effect of 105,000gx60 mjn. pellet of lyophilized
placental mitochondrial suspension on
cholesterol side - chain deayage activity.
(1ml Equivalent to 15mg lyophilized placental mitochondria)
Pig. 3.9b. The data of pig. 3.9a plotted according to
Dixon (1953) •
(v = percentage conversion)
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Specificity of the endogenous inhibitor
The best studied mitochondrial steroid hydroxylase
has been the steroid IIP-hydroxylase of adrenocortical
mitochondria that hydroxylates 11-deoxycorticosterone (DOC)
to produce corticosterone (see Simpson et al., 1969).
Placental mitochondrial aoetone powders (and also lyophilized
preparations) were assayed for steroid 11g-hydroxylase activity
using the method described by Simpson and Estabrook (1969).
Steroid llg-hydroxylase activity was not observed in either
the mitochondrial suspensions or the 105»000 g« x 60 min.
supernatants. This was in agreement with the observations
of Billiar and Little (1966). Thus it was not possible to
study the action of the endogenous inhibitor on a placental
llg-hydroxylase.
It was seen earlier in this chapter that placental mito¬
chondrial preparations contained an active 33-hydroxysteroid
dehydrogenase-A^"""^isomerase system. Mitochondrial acetone
powder preparations from which the inhibitor had been removed
had a very active dehydrogenase system associated with the
105»000 g. x 60 min. pellet (Table 3.10) and were used as the
enzyme source. Lyophilized placental mitochondria were
suspended in 0*1 M KCl, centrifuged at 105,000 g. x 60 min.
as usual and the pellet resuspended in distilled water (20 ml.
pellet suspension from 300 mg. lyophilized mitochondria).
Varying amounts of the pellet suspension were added to the
dehydrogenase assay system (see Chapter 2) which employed
[^-^C] pregnenolone as the substrate and NAD+ as the cofactor.
It was observed (Table 3*13) that addition of large amounts
TABLE3.13
EFFECTOFTHE105,000g.x6MIN.PELL( -^OFLYOPHILIZEDP AC NTALMITO HONDRIA












ConcentrationfS^equivale tto2l±mg.lyoph lizedmitochondriaeincub ion
Effect of lecithin on the cholesterol side-chain cleavage
activity of the 105,000g x 60min extract from lyophilized
bovine adrenocortical mitochondria.
Pig. 3.IO. Effect of authentic lecithin on the
cholesterol side-chain cleavage activity




of the pellet suspension resulted in greatly enhanced
dehydrogenase activity - due to the dehydrogenase being
present in the pellet suspension. Thus the inhibitor did
not interfere in the metabolism of pregnenolone by the dehydro¬
genase system. Presumably there was no interaction between
the inhibitor and pregnenolone.
Absence of the endogenous inhibitor in the mitochondria of
other sterold-producing tissues
Simpson (1967) in studies with bovine adrenocortical
mitochondria and Sulimoviei and Boyd (1968b) using immature
rat ovarian mitochondria both observed enhanced cholesterol
metabolism to the steroid hormones after ultrasonication of
the mitochondria. They attributed the increased activity
to the possibly easier penetration of the exogenous tracer
cholesterol to the substrate binding site of the enzyme.
Placental mitochondria appear, therefore, to be different in
some way to the other tissue mitochondria capable of con¬
verting cholesterol to the steroid hormones. If the inhibitory
substance is phospholipid, this poses a problem since the
mitoohondria of these other tissues have reasonably similar
phospholipid compositions. The effect, therefore, of a pure
phospholipid-lecithin - upon the cholesterol side-chain cleavage
activity of a 105,000 g. x 60 min. supernatant of lyophilized
adrenocortical mitochondria was investigated. The procedure
was similar to that used earlier for the placental enzyme.
The results are summarised in Pig. 3.10. Though the adrenal
enzyme was sensitive to the presence of lecithin, a lecithin
concentration of 1*0 mg./fol. was required to produce 50$
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inhibition, whereas O'ij. tag./ml. produced a similar degree
of inhibition of the placental enzyme.
It seemed possible that the difference in sensitivity
of the placental and adrenal supernatant enzymes to a pure
phospholipid and their respective "pellet" fractions might
just be a reflection of the enzyme concentration in the mito¬
chondria. Adrenocortical mitochondria are certainly more
active than a similar amount of placental mitochondria when
cholesterol side-chain cleavage activity is compared (Simpson,
1967 and present study). To test this hypothesis, 150 mg.
lyophilized adrenocortical mitochondria were suspended in
10 ml. 0*1 M KC1 and centrifuged at 105,000 g. for 30 minutes.
0*5 ml. aliquots of the resulting supernatant (1 ml. equivalent
to 15 mg. lyophilized mitochondria; protein concentration,
1*7 mg./nl.) were incubated with varying amounts of the
residual pellet which was suspended in water (1 ml. equivalent
to 15 mg. lyophilized mitochondria; protein concentration,
mg./ml.) The standard cholesterol side-chain cleavage
assay was used, employing a 30 minutes incubation period. The
pellet suspension was heated in a boiling water bath for 10
minutes prior to the incubations, in order to destroy residual
cholesterol side-chain cleavage activity. This procedure
permitted a study of 'the effect of large amounts of 'pellet*
upon relatively small amounts of the adrenal enzyme. The
results are shown in Table 3-11+- It was seen that the adrenal
cholesterol side-chain cleavage enzyme was inhibited by
particulate mitochondrial material under such conditions.
It thus appeared that the relatively small amount of
TABLE3.Ill
EFFECTOF105,000g.x6MIN.PELLETFALYOPHILIZEDADR NOCOR ICALMITO H NDRIAL PREPARATIONONTHECHOLES ROLSID -CHAINCLE VAGEACTIVITYFOWCONCENTRATION OFTHEENZYMEPRES NTIT105,000g.x6MI .SUPERNATANT( ^OFTHEMITOC ONDRIAL PREPARATION Amountfadre allyoph.ilized105,000g.x6min. pelletadd d(equival nttomg.lyophilized mitochondria) None 7*5 22*5 l+5'O
Percentageconversion of[i|.-^^c]cholesterol toC^^products 2i+*2 9-1 1+*8 5*3
Amountfpresentwaseq ivalentt7*5tag*lyophilizedmitocho dria
Effect of lOS.OOOg.xSOmin. pellet from lyophilized










3.11, The data of Pig. 3.9a. plotted according
to Reiner (1969).
(i = fractional inhibition)
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the cholesterol side-chain cleavage enzyme played an
important role in the inhibitory process. The results suggested
a phospholipid-cholesterol-enzyme interaction, possibly in¬
volving micelle formation. In the placental situation, a
critical micellar concentration is reached, resulting in an
inhibition of activity for some reason. However, in the
adrenal situation, the enssyme concentration is higher and the
critical micellar concentration is surpassed with relation to
protein concentration. An ,inhibitoryt micelle is therefore
not formed and enzyraic activity is observed.
Further evidence for the critical involvement of the
enzyme in the inhibitory process was obtained by plotting the
data of Fig. 3.9a. according to Reiner (1969). The plot is
y 5 ^ versus the inhibitor concentration, where i is the
fractional inhibition, and is shown in Fig. 3.11. The plot
was found to be a straight line, which is indicative of an
enzyme-substrate-inhibitor interaction to produce an inactive
complex. A purely substrate-inhibitor interaction to produce
an inactive complex is expected to give a curved plot. This
result confirmed the involvement of the enzyme in the
inhibitory process.
The mechanism of the inhibition will be considered more
fully in the Discussion.
CHAPTER ii.
CHARACTERISTICS OP THE 'SOLUBILISED*
PLACENTAL CHOLESTEROL SIDE-CHAIN
CLEAVAGE ENZYME SYSTEM
6-4 6-0 7-2 7-6
PH
80
pH-activity profile of a 105»000 g. x 60 rain,
supernatant; of lyophilized placental mito¬
chondria. The buffer employed was phosphate.
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CHARACTERISTIC S OF THE 'SOLUBILIZED' PLACENTAL CHOLESTEROL
SIDE-CHAIN CLEAVAGE ENZYME SYSTEM
Effect of pH
The cholesterol side-chain cleavage enzyme assays were
performed as described in Chapter 2, using phosphate buffers
of varying pH. The enzyme source was a 105,000 g. x 60 min.
supernatant of a lyophllized placental mitochondrial suspen¬
sion in 0*1 M KCl. The results are shown in Pig. i|.. 1. The
pH-activity profile was found to have quite a broad maximum
with a maximal activity in the region of pH ?• Thus the
enzyme activity is not very sensitive to the pH between 6*5
and 8*0. Routine assays were carried out at pH 7'l+»#
close to the physiological pH.
Effect of NADPH
A characteristic of mammalian steroid mixed-function
oxidases is that they appear to have a specific requirement
for NADPH. It was found that the placental cholesterol
side-chain enzyme appeared to have a specific requirement
for NADPH, since NADH (at concentrations up to 1 mM) did
not support cholesterol side-chain cleavage activity.
The NADPH concentration (produced using the NADPH
generator system) used in the routine assay was 0*5 mM.
However, very much lower concentrations of NADPH were re¬
quired to produce any effect on the enzymic activity.
Figure 1+.2 shows the effect of NADPH on the cholesterol side-
chain cleavage activity of a 105#00Gg. x 60 min. supernatant
of lyophilized placental mitochondria (protein concentration,
4 mg./ml.) plotted according to Lineweaver and Burk (19314-).
Pig. 4.2. A U.neweaver-Burk plot to determine the for
NADPH of the cholesterol side-chain cleavage
enzyme of supernatant of lyophilized placental
mitochondria.
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mM
PHOSPHATE
Effect of phosphate on the conversion of
cholesterol - 4 - UC to pregnenolone-4-UC
and progesterone - 4 - H by a lyophilised
placental mitochondrial preparation
Pig. 4.3. Effect of (sodium) phosphate buffer, pH 7'h*
on the cholesterol side-chain cleavage activity
of supernatant of lyophilized placental
mitochondria.
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The intercept on the abscissa allowed the calculation of
an apparent Km value for NADPH. It was found to be about
1 pM. The assays were performed in the presence of 200 pg
of added cholesterol in addition to the tracer cholesterol
to ensure saturating levels of the substrate. The NADPH
concentration was varied by addition of different amounts
of NADP+ plus 10 pmbles of glucose-6-phosphate and 0*25 i-u.
of glucose-6-phosphate dehydrogenase.
Concentrations of NADPH from 2 pM to 0*5 mM did not have
much effect on the cholesterol side-chain cleavage activity,
in disagreement with the observations of Satoh et al. (1966)
who observed that 0*5 mM NADPH strongly inhibited the adreno¬
cortical cholesterol side-chain cleavage enzyme. NADPH
concentrations greater than 0*5 mM did, however, slightly
inhibit the enzymic activity.
Effect of salt concentration
It was observed that variations in the phosphate buffer
concentration of the standard assay system for the solubilised
enzyme produced a marked effect on the cholesterol side-
chain cleavage activity. The observations are recorded in
Pig. Ip-3* Increasing concentrations of phosphate were found
to produce an increasing inhibition of the cholesterol side-
chain cleavage activity of the lyophilized mitochondrial
extract. 200 mM phosphate almost completely abolished the
cholesterol side-chain cleavage activity. Satoh et al.
(1966) reported a similar effect of phosphate on the cholesterol
side-chain cleavage activity of an acetone powder extract of
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Pig. Effect of various buffer salts at pH 7'li¬
on the cholesterol side-chain cleavage
activity of a lyophilized placental
mitochondrial extract.
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requirement for NADPH by the enzyme system, the possibility
existed of competition between the phosphate groups of the
oofactor and the buffer salt at the coenzyme binding site.
However, doubling the NADPH concentration did not produce
any increase in enzymic activity; in fact, increasing the
NADPH concentration to 1 mM produced a slight decrease in
the enzymic activity. Table I4.. 1 presents the data obtained
when the NADPH concentration was doubled at increasing
phosphate concentrations.
Several other buffer systems were then used to investi¬
gate the specificity of the phosphate inhibition. These
included triethanolaminxe-HCl, Tris-HCl, glycylglycine-HCl
and citrate, all at pH Cholesterol side-chain cleavage
assays were carried out at varying concentrations of these
buffers. The results are summarised in Pig. It was
seen that inhibition of enzymic activity occurred with
increasing concentrations of all the buffers investigated.
Assays were also conducted at a fixed phosphate concentration
(20 mM) but with an increasing salt concentration using
potassium chloride (see also Pig. This confirmed
that the inhibition was a function of the salt concentration.
Thus the solubilised cholesterol side-chain cleavage enzyme
activity was sensitive to the salt concentration rather than
to a specific ion such as phosphate.
In order to investigate whether the salt inhibitory
effect was reversible or not, the following experiment was
carried out.
300 mg. lyophilized placental mitochondria were taken
TABLE k.l
EFFECT OF PHOSPHATE ON THE CHOLESTEROL SIDE-CHAIN CLEAVAGE
ACTIVITY AT TWO DIFFERENT NADPH CONCENTRATIONS
Phosphate pH 7*lj. NADPH
(raM) 0-5 mM 1-0 mM
10 35*7 30-5
50 26-0 2^-3
190 9*0 10* 9
The enzymic activity is expressed as the percentage
conversion of [ij.-^C ] cholesterol to C21 products in
60 rain, at 37°C. The enzyme source was a 105,000 g. x
60 min. supernatant of a lyophilized mitochondrial
preparation.
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up In 10 ml. 0*1 M phosphate pH 7'k and centrifuged at
105#000 g. x 60 min. The supernatant was divided into
two portions. To one portion was added NaCl (final
concentration 1 M) and the portion was left at ij.0G for 1 hour.
After this time, both portions were dialysed against O'Ol^. M
phosphate, pH 7'kt ?°r 3 hours (3 changes). Cholesterol
side-chain cleavage activity assays were then performed in
the normal manner using 1*0 ml. aliquots of the two portions.
The results are shown in Table i^.2. It appears that the
salt effect was reversible; in fact, a small increase in
activity was observed. It is very possible that the state
of aggregation (or disaggregation) of the enzyme complex
is important with regard to enzymic activity. One must
conclude from these results that maximal enzymic activity
is associated with a minimal ionic strength of the assay
medium. However, the salt (buffer) concentration must be
sufficient to maintain the hydrogen ion concentration near
the optimum pH of the enzyme. The inhibitory effect of
high salt concentrations will have to be taken into
consideration when the effect of such compounds as thiols
on cholesterol side-ohain cleavage activity is studied. How¬
ever, the inhibitory effect of high salt concentrations on
the enzymic activity does appear reversible.
Effect of phosphate concentration upon the cholesterol side-
chain cleavage activity of native placental mitochondria
Since high phosphate concentrations were inhibitory to
the activity of the solubilised enzyme system, the effect
on the enzymio activity of native placental mitochondrial
TABLEU..2
EFFECTOFXPOSURETAHIGHSALCONCENTRATION(1MNa l)HCHOL STEROLS DE- CHAINLEAVAGEACTI ITYOF105,000g.x6M N.SUPERNA ANTLYOPHILIZ DPLACENTAL MITOCHONDRIALPREPARATION Percentageonversionf[ii-^^c]holester l toC^productsIn60min.at37°C Control10-7 Sampleexposedto1MNaClf r60in., thendialysed13*3 Eachincubationcontainedequivale tt30mg.lyoph lizitocho dria
(mM)
Fig. I4.. 5. Effect of p-me reap to-ethylamine on the
cholesterol side-chain cleavage activities
of placental native mitochondria and lyophilize
mitochondrial extracts.
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preparations was investigated. The results, displayed in
Table I4..3, show that increasing phosphate concentrations have
little effect on the cholesterol side-chain cleavage
activity of native mitochondria. However, the levels of
enzymic activity in the native mitochondria were very
much smaller than in the solubilised preparations and
significant differences were less readily seen.
Effect of thiol compounds
There is an increasing amount of evidence supporting
the importance of . sulphydryl groups - both of the cytochrome
P-ij.50 and of the non-haem iron protein - in the structure
and catalytic activity of hydroxylases similar to the
cholesterol side-chain cleavage enzyme system (Mason et al.,
1963). Thiol compounds such as 3-mercaptoethylamine appear
especially important for cholesterol 7a-hydroxylase activity
(Scholan, 1969). In this instance, 3-mercaptoethylamine
appears to direct the oxygen attack to the 7a position,
whilst suppressing free radical type reactions which give
rise to a wide range of autoxidative products. sulimovici
and Boyd (1968a) observed that 3-mercapto-ethylamine (1-10 mM)
produced some stimulation of the cholesterol side-chain
cleavage activity of native rat ovarian mitochondria. Higher
concentrations of the thiol were found to be inhibitory.
Figure I4..5 illustrates the effect of varying concen¬
trations of 3-mercapto-ethylamine on the cholesterol side-
chain cleavage activity of native placental mitochondria.
At low concentrations of the 8-mercapto-ethylamine (1-3 mM),
some stimulation of cholesterol side-chain cleavage aotivity
TABLEli.3



























Fie k.6. Effect of cysteine on the cholesterol side-
chain cleavage activities of placental native
mitochondria and lyophilized mitochondrial
fixtTacts
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was observed; higher concentrations were inhibitory.
Figure k»5 also shows the effect of 3-mercapto-ethylamine
on the solubilised enzyme (from lyophilized mitochondria)
when the thiol was found to be inhibitory; 8 mM 3-mercapto-
ethylamine produced about 50$ inhibition.
Figure i^.6 illustrates the observations made on the
cholesterol side-chain cleavage activities of native and
solubilised mitochondrial preparations in the presence of
increasing amounts of cysteine. The cysteine solution was
brought to pH 7*li- with KOH prior to addition to the
incubations. In both preparations, cysteine had no significant
effect on the cholesterol side-chain cleavage activity.
The effect of reduced glutathione on the cholesterol
side-chain cleavage activities of native and solubilised
placental mitochondrial preparations is shown in Fig. !(..7.
Glutathione at low concentrations around 0*5 mM did stimulate
the native mitochondrial activity; otherwise glutathione
had no significant effect on the enzymic activity.
In the absence of NADPH, none of the three thiols
supported the enzymic activity. This is in contrast to
the oxygenase involved in the biosynthesis of prostaglandins
which utilizes glutathione (reduced)(Nugteren et ai., 1966).
Other thiol compounds such as 6-mercapto-ethanol, homo¬
cysteine, and dithiothreitol were also tested. B-mercapto-
ethanol and homocysteine were found to have little effect
on the enzyme activity in the concentration range (0-20 mM)
investigated. Dithiothreitol inhibited the solubilised












Pig. 1+.7. Effect of glutathione (reduced) on the
cholesterol side-chain cleavage activities
of placental native mitochondria and
lyophilized mitochondrial extracts.
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In general, none of the thiol compounds studied had
a marked stimulatory effect on the cholesterol side-chain
cleavage activity. Some stimulation was observed at low
concentrations using native mitochondrial preparations. In
these instances, the observed effect could possibly be
attributed to an effect on the permeability of the mitochondria
to NADPH. i.e. an indirect effect on the supply of reducing
equivalents rather than a direct involvement at the enzyme
level.
NADPH was always required and no evidence was obtained
for the substitution of NADPH as the electron donor by any
of the thiol compounds. The thiol compounds apparently had
no protective effect on the enzyme system as measured by any
significant increase in enzymic activity.
Activation Energy of the cholesterol side-chain cleavage
reaction in placental mitochondria.
Sterol mono-oxygenases such as the Steroid llg-hydroxy-
lase and the cholesterol side-chain cleavage enzyme are
concerned in reactions which involve both oxygenation and
oxidation. The enzymes catalyse the introduction of
molecular oxygen into the substrate molecule. They also
require the presence of an external electron donor. In the
case of most mammalian mono-oxygenases the donor is NADPH.
Due to the dual requirement for molecular oxygen and an
electron donor, Mason (1957) termed these enzymes as "mixed-
function oxidases". The cholesterol side-chain cleavage
reaction involves the oxidation of both cholesterol and
NADPH. i.e. the coupling of two exergonic reactions. The
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overall redox potential arising from the transfer of
electrons from NADPH to molecular oxygen along the mito¬
chondrial respiratory chain is over 50 Kcal mole""''. Thus
the oxidation of NADPH in a hydroxylase reaction is energe¬
tically expensive. It seemed therefore likely that
considerable energy was required in an activation step -
either activation of the substrate or the oxygen. Since
molecular oxygen is a comparatively inert substance, the
activation of the oxygen into a reactive species could be
the important energy requiring process. It was decided,
therefore, to determine the activation energy of the
cholesterol side-chain cleavage reaction. It was thought
that this value could be meaningful in any energetic consider¬
ation of the reaction mechanism.
The procedure for the determination of the activation
energy of the reaction was as follows: Placental mitochondrial
acetone powder extracts (prepared as described earlier) were
incubated with cholesterol and NADPH using the normal
assay system. Incubations were performed in duplicate at
varying temperatures between 2lj° - 37°C (increments of 2-3°C).
The incubation periods were such that the initial velocity
could be expressed validly as a function of the enzymic
activity. The normal incubation period was 10 minutes and
the rate of production of metabolites was linear over this
time period. The temperature of the incubation bath was
taken at 2 minute intervals during the incubation. This
permitted a mean temperature value to be obtained. The
influence of temperature on the reaction velocity can be
Pig. ij.. 8. An Arrhenius plot to show the effect of
temperature on the rate of the cholesterol
side-chain cleavage reaction (v - percentage
conversion in 10 minutes, x 10).
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expressed in the form of the Arrhenius equation, given
below.
k = Ae-E/^T (C)
where k is the specific reaction rate, e~E/^T is the
Boltzmann factor, A is a constant, sometimes called the
frequency factor and E is the energy of activation of the
reaction.
Taking logarithms of equation (C), it is found that
log k = log A - 2«j03RT
This requires a plot of log k against 1/f to be linear,
the gradient being equal to - E/2*303R. The activation
energy, E, which is a constant and a characteristic of the
reaction, can thus be calculated from the value of this slope.
The enzymic activity at eaoh temperature was taken as^a
measure of the specific reaction rate, k. Hence there was a
need for short incubation periods to ensure a linear relation¬
ship between k and the enzymic activity. Figure 1^.8 shows
a typical plot of log v against 1/T for the cholesterol
side-chain cleavage reaction occurring in placental mito¬
chondrial extracts. The mean value of E obtained was
-18*I4. + 2*5 kcal mole-"*" (I4. separate experiments). This is
a relatively high activation energy and is comparable to the
activation energy of the liver microsomal cholesterol 7a-
hydroxylase which was found to be -22 ± ij. kcal mole-^" (Boyd,
1970). It appears possible that there is a common activation
step in the two enzymic reactions. Unfortunately these
two values of activation energies could not be compared with
those for other mixed function oxidases, since the literature
appeared devoid of such estimations. However, George and
Stratmann (1952) and very recently Brown and Mebine (1969)
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have determined the activation energy of the reaction in¬
volving the autoxidation of oxymyoglobin to metmyoglobin.
Activation energies obtained with myoglobins from different
sources ranged fvom~2l\.-27 kcal mole "*"• One can speculate
that the activation of oxygen by these enzymes could be
the important energy-requiring process. Although in its
ground state molecular oxygen has two unpaired electrons
(triplet state) and is paramagnetic, it does not behave
chemically as a biradical. Molecular oxygen is fairly
inert, its apparent reactivity being due to the activated
species 0*, OH*, R02*, able to initiate chain reactions.
Free radical species derived from oxygen have frequently
been proposed as intermediates in biochemical reactions
(Norman and Radda, 1962} Yamazaki and Piette, 1963;
Staudinger and Ullrich, 196i|). Oxygen reduction can, in
principle, occur in four single electron steps:
02 + e + H+ «£==? H02*
HO* + e + H+ ^ - H202
H202 + e + H+ »• OH* + H20
OH* + e + H+ H20.
The redox potentials at pH 7 for these reactions have been
calculated as about, -0*6, + 1*1, + 0*lp, and + 2*3 V"
respectively (George, 1965; Mason, 1965)# Thus quite strong
reducing conditions are required to add the first electron
to oxygen, and the two free radicals, H02* and OH*, are
oxidising agents, the latter a powerful one. There is also
the possibility of oxygen atoms being formed in the reduction,
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by the 0—0 bond breaking in the second of the above reactions
to give water and 0*, instead of (George, 1965).
The formation and reactions of a number of oxygen free
radicals have been quite extensively studied by physical
chemists. Both HO2* and OH* can undergo acid dissociations,
giving 0^" and 0~ respectively, with pK values of I4/5 and 11*9
(Schested, Rasmussen and Fricke, 1968; Rabani and Matheson,
1964). Thus at pH values of biochemical interest 02*" and
OH* might occur; HO^, also being a possible species in the
lower pH range. There appears to be no conclusive evidence
for the existence of the species 0H+ (Samuel, 1968).
Radiation work has given data on the lifetimes of the oxygen
radicals. In the neutral pH range, both 0^'~ and H02*
have half-lives of tens of milliseconds (Czapski and Dorfman,
196lp). In the alkaline region, the stability of 02*~ is
markedly increased, e.g. it has a half-life of about 200 ms
at pH 10 (see Bray, 1970). °2*~ 1188 been ot)served Knowles
et al. (1969) using electron paramagnetic resonance, during
xanthine oxidase-catalysed oxidation of substrates by oxygen
at pH 10. It must be remembered, however, that 02*"" is
the most stable oxygen radical in the alkaline region. Prom
the work of Komai et al. (1969) it appears that it is the
flavin of the reduced enzyme molecule that reacts with oxygen
in producing this radical.
OH* is the active hydroxylating species of Fenton's
reagent (Norman and Lindsay-Smith, 1965). However, direct
evidence on the possible involvement of this radical oust
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await the evolution of new methods.
The nature of the active oxygen species still remains
to be elucidated. The value of the activation energy
obtained for the cholesterol side-chain cleavage mixed function
oxidation partially explains the requirement for the powerful
reducing agent NADPH.
CHAPTER 5
COMPONENTS OP THE PLACENTAL MITOCHONDRIAL
CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME SYSTEM
71
COMPONENTS OP THE PLACENTAL MITOCHONDRIAL CHOLESTEROL
SIDE-CHAIN CLEAVAGE ENZYME SYSTEM
The presence of cytochrome P-U50 in placental mitochondria
Adrenocortical mitochondria possess a very active
cholesterol side-chain cleavage enzyme system and have con¬
siderable amounts of cytochrome P-^.50 (Simpson and Boyd,
1966, 196?a). These workers showed that cytochrome P-i+50
was involved in the cholesterol side-chain cleavage enzyme
on the basis of carbon monoxide inhibition studies together
with the release of this inhibition by light, maximal
release of the inhibition occurring with light of wavelength
ij.50 nm. However, other endocrine tissues which are known
to possess an active cholesterol side-chain cleavage enzyme
system appear to contain much smaller amounts of cytochrome
P-U50 compared to the adrenal cortex. Cooper (1970) has
reported that the cytochrome P-l+50 content of rat ovarian
mitochondria is about one tenth that of rat adrenal mito¬
chondria. The rat ovarian mitochondria possess a very
active cholesterol side-chain cleavage enzyme system
(Sulimovici and Boyd, 1968a). Rat testis mitochondria are
capable of cleaving the cholesterol side-chain (Manon et al.,
1965) but the cytochrome P-I4.5O content of testis mitochondria
is very low (Machino et al., 1969).
In a study of placental drug metabolising systems,
Juchau et al. (1968) failed to detect cytochrome P-I4.50 in
placental preparations; this contrasts with the liver in
which cytochrome P-I4.5O Is frequently involved in drug
\
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metabolism. They suggested, since certain steroid hydroxy-
lation reactions had been demonstrated in placental tissue,
that the electron transport chain for such hydroxylations
might utilise a different cytochrome system. However,
Meigs and Ryan (1968) demonstrated the presence of cytochrome
P-450 in both placental mitochondria and microsomes. The
mean cytochrome P-I4.3O contents reported by these authors
were 0*123 nmole per mg. mitochondrial protein and 0*0ip2 nmole
per mg. microsomal protein. The absolute amounts of cyto¬
chrome P-i4.50 in placental particles are, therefore, approx¬
imately one tenth those calculated from date on the adrenal
cytochrome P-I4.5O content (Harding and Nelson, 1966).
In the present study the search for spectroscopic
evidence for the presence of cytochrome P-i|30 in placental
mitochondria was made very difficult by the presence of
contaminating haemoglobin. Carboxyhaemoglobin has a maximum
absorption peak at i\20 nra. which is similar to that of cyto¬
chrome P-i|20. Since placental tissue has a very good blood
supply, this made it very difficult to remove all traces of
haemoglobin prior to homogenisation. However, considerable
amounts were removed by 'washing' the tissue with either
0*9$ NaCl solution or 0*23 M sucrose. Repeated 'washing'
of the mitochondrial fraction also aided the removal of
some of the remaining haemoglobin. However, there was
always a trace of haemoglobin that remained firmly associated
with the mitochondria. The presence of this haemoglobin
complicated the spectral search for the small amounts of
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Pig. 5«1* Tile reduced carbon monoxide difference
spectrum of (a) the 105,000 g. x 60 min.
supernatant of lyophilized placental mito¬
chondria (b) the 105,000 g. x 60 min. pellet
of the same mitochondrial preparation.
A reaction cuvette containing dithionite was
gassed with GO; a reference cuvette contained
dithionite.
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reduced (dithionite) carbon monoxide difference spectrum
of the 105*000 g. x 60 min. supernatant from a lyophilized
placental mitochondrial suspension in 0*1 M phosphate
buffer pH 7*U- (equivalent to 2 mg.mitochondrial protein
per ml.). The 105*000 g. x 60 min. pellet was resuspended
in 0*1 M phosphate, pH 7'h-* and a similar reduced, carbon
monoxide difference spectrum obtained (9 mg. mitochondrial
protein per ml.). This is shown in Pig. 5»l(b). The
spectra were obtained using a Unicam S.P. 800 recording
spectrophotometer with a scale expansion accessory. As
can be seen in Pig. 5»1* both the supernatant and the pellet
contained material which gave a maximum absorption at 1^20 nm
- certainly almost entirely due to contaminating haemoglobin.
The difference in absorbance readings at I45O nm and 1+90 nm
obtained from the CO difference spectrum of dithionite
reduced preparations was used to calculate the cytochrome
P-l|.50 content with the extinction coefficient of 91 mM~^cm"*^
(Omura and Sato, 1961|b). The cytochrome P-I4.5O content of
the 105,000 g. x 60 min. pellet was found to be 0*05 nraole
per mg. mitochondrial protein. Due to the contaminating
haemoglobin, the cytochrome P-l|20 content could not be
assessed. It could be speculated that there was a very
small amount of cytochrome P-J4.50 in the supernatant prepar¬
ation from the mitochondria - too small to estimate. How¬
ever, it should be noted that the cholesterol side-chain
cleavage activity was located only in the supernatant fraction
from a mitochondrial preparation (see Chapter 3). It
appeared therefore that the amount of cytochrome P-i|50
involved in placental cholesterol side-chain cleavage
activity was very small.
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Effect of Carbon Monoxide on the cholesterol side-chain
cleavage reaction in human placenta
Simpson and Boyd (1966) observed that the cholesterol
side-chain cleavage reaction in bovine adrenocortical mito¬
chondria was sensitive to carbon monoxide. Previously
Harding et al. (1965) had shown that steroid IIP-hydroxylase
activity in the same tissue was inhibited by carbon monoxide.
The haemoprotein, cytochrome P-I4.5O, was believed from these
studies to be the carbon monoxide sensitive component .
These observations were presented as evidence for the involve¬
ment of cytochrome P-l^O in the llp-hydroxylation of
deoxycorticosterone and the cholesterol side-chain cleavage
reaction. The effect of carbon monoxide on the cholesterol
side-chain cleavage reaction of human placental mitochondria
was therefore investigated.
These studies were carried out in a similar manner to
those described by Simpson and Boyd (1966). The apparatus
used in this investigation is described below.
Carbon monoxide was prepared by the action of conc.
sulphuric acid on formic acid (both Analar grade). The gas
was bubbled through water to remove acid vapours, then through
chromous chloride to remove oxygen and finally through
potassium hydroxide pellets to dry the gas. Nitrogen was
also bubbled through chromous chloride solution to ensure it
was oxygen free. Appropriate gas mixtures were prepared
in one litre burettes. Incubations were carried out in
standard 25 ml. Erlenmeyer flasks. The flasks were fitted
with rubber stoppers drilled to permit insertion of hypodermic
syringe needles - one needle being connected to the gas burette
Pig. 5.2. Effect of carbon monoxide/oxygen ratio
on the rate of the cholesterol side-chain
cleavage reaction in supernatant of a
placental mitochondrial sonicate.
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by means of rubber tubing, the second shorter needle being
used to control the gas outflow from the flask. Gas
mixtures were bubbles through the flasks by maintaining a
constant head of pressure. The flasks were contained in
a shaking incubation bath maintained at 37°G* This system
is an open one, in contrast to the closed system of Warburg
(191^.9) and Estabrook et al. (1963).
The standard incubation mixture of Table 3.1 was made
up as usual, but omitting the cholesterol-i|-"^C substrate.
The enzyme source was a 105,000 g. x 60 min. supernatant
from sonicated placental mitochondria. A period of 5 min.
after the commencement of the bubbling of the appropriate
gas mixture was allowed for the contents to reach equilibrium
with respect to the temperature, the gas composition and the
state of reduction of the NADP. The [l^^C] cholesterol
tracer was then added using an Agla syringe by removing the
outlet tube and inserting the syringe through the hole in
the rubber stopper. The incubation was allowed to proceed
for one hour and then terminated with the addition of methanol
and extracted in the normal manner.
The numerical results are shown in Pig. 5»2. As the
carbon monoxide content of the gas phase was increased there
was a corresponding decrease in the activity of the
cholesterol side-chain cleavage enzyme system.
Calculation of the Partition Constant
Warburg (191+9) derived the following expression to
account for the inhibition of cellular respiration by carbon
monoxide. In the case of the cholesterol side-chain
i - T2
Fig. 5.3. Plot of 5 0 versus ~ for
co 2
ro
cholesterol side-chain cleavage reaction.
The gradient is 1/K.
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cleavage enzyme system, it is assumed that carbon monoxide
is competing with oxygen for an enzyme site resulting in
inhibition of the enzymic activity.
For the reaction -
E.02 + GO S=s=3* E. GO + 02 ;
where E is the enzyme binding site, the equilibrium constant K













where r__ is the reaction rate in the presence of carbonc u
monoxide and rQ the reaction rate when no carbon monoxide is
present. The equilibrium constant K is known as the







a straight line of gradient 1/K should be obtained.
Figure 5*3 shows the results of plotting the data
of Figure 5.2 in this way. It can be seen that the points
give a reasonable fit to a straight line. The value of K
obtained, calculated on the assumption that line passes
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through, the origin, is - K = 1'1± ± 0*2 (s.d.) where k = k.
Simpson and Boyd (1966) obtained values for the
partition constant varying between 0*2 and 1*2 in a study
of the bovine adrenocortical mitochondrial cholesterol side-
chain cleavage enzyme. The present finding is also in
keeping with those of Estabrook et al. (1963) who quote
values between 0*6 and 1*8 for the partition constant for
the steroid 21-hydroxylase of adrenal cortex microsomes.
Simpson and Boyd (1966) also found a correlation between the
concentration of carbon monoxide in the gas phase and the
size of the cytochrome P-l|50 chromophore. This enabled the
partition constant for cytochrome P-^50 to be obtained.
However, due to presence of only very small amounts of
cytochrome P-ij.50 in the solubilised placental mitochondrial
preparations, no such studies were carried out in this
investigation.
Thus, in common with several other mixed-function
oxidases, and more particularly the steroid 110- and 21-
hydroxylases and the cholesterol side-chain cleavage enzyme
of the adrenal cortex, the cholesterol side-chain cleavage
enzyme of human placental mitochondria is inhibited by
carbon monoxide. This is in agreement, with the results of
Meigs and Ryan (1968) on the effect of carbon monoxide on
the placental cholesterol side-chain cleavage enzyme. These
workers do not quote a partition constant for comparison
with the one obtained in this study. Furthermore, the kinetics
of this inhibition are consistent with a competition between
oxygen and carbon monoxide for a common binding site. Such
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competition is a well known feature of several haemoproteins
such, as haemoglobin and cytochrome oxidase. The partition
constant for the placental cholesterol side-chain cleavage
enzyme is about unity, and therefore similar to that for
other steroid hydroxylases. This value for mixed function
oxidases is quite different from the partition constants of
haemoglobin and cytochrome oxidase which are 1*8 - 8*0 x 10~^
and 10 - 20 respectively. (Keilin and Wang, 19l|6). It is,
however, very similar to the partition constant for cytochrome
P-U50, which was calculated for the adrenal cortex mitochon¬
drial cytochrome P-l|50 (Simpson and Boyd, 1966) to be
1*07 + 0*30. This suggests the possibility that cytochrome
P-I45O may be involved as the oxygen-binding site for the
cholesterol side-chain cleavage enzyme of human placental
mitochondria.
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Effect of light on the carbon monoxide Inhibition of the
plaoental cholesterol aide-chain cleavage reaction
A characteristic of the carbon monoxide complexes of
haemoproteins is that the enzyme—CO combination can be dis¬
sociated by light of the appropriate wavelength, Estabrook
et al., (1963) and Omura et al., (1963) showed that the
carbon monoxide inhibition of mixed-function oxidases, and
particularly the steroid 21-hydroxylase, was light reversible
and furthermore, that the most effective wavelength for
reversing the carbon monoxide inhibition in the presence of
oxygen was 450 nm. This very much strengthened the evidence
for the involvement of cytochrome P-450 as the site of oxygen
binding in these mixed-function oxidases. Simpson and
Boyd (1967a) examined the light reversibility of the
cholesterol side-chain cleavage system of adrenocortical
mitochondria. The inhibition was found to be light reversible,
the most effective wavelength again being 450 nm. This was
convincing evidence for the involvement of cytochrome P-450
in the adrenal cholesterol side-chain cleavage enzyme system.
It was decided, therefore, to examine the light reversibility
of the carbon monoxide inhibition of the placental cholesterol
side-chain cleavage activity.
According to the theory of Warburg (1949), the partition
















k. Apparatus for the study of the light
reversal of the carbon monoxide inhibition
of cholesterol side-chain cleavage activity.
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where subscript 1 refers to reactions in the presence of light
The percentage displacement of the partition constant -
AK
_ K1 " Kd
^ " *9"




where L is a proportionality factor called the "light
sensitivity" of which the dimensions are a reciprocal of
intensity. Hence plotting L against the wavelength of the
incident light gives the photo-chemical action spectrum of
the carbon monoxide-sensitive system and reveals the wave¬
length which is the most effective in reversing the carbon
monoxide inhibition in the presence of oxygen.
Experimental procedure. This was essentially as described
by Simpson and Boyd (1967a)* The light source was a
250 watt high pressure Xenon lamp. Since the degree of
reversal of inhibition is proportional to the light intensity,
the area of illumination was reduced as much as possible,
whilst at the same time ensuring uniform illumination of the
entire solution. The experimental arrangement is shown in
Pig. Th® optical cuvette provided an incident area of
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about 2 cm . A mirror was placed behind the cuvette, in
order to increase the light flux. The cuvette was kept
at 37°C in the Unlearn water-jaoketed cell holder. The
lamp was enclosed in an aluminium shielding blackened on
the inside, except for a slit. The lens was so arranged
as to cause the light beam from the slit to focus on the
cuvette. The filters used were interference filters (Grubb
Parsons Ltd., Newcastle-upon-Tyne). The average band
width was 8-10 nm. The relative intensity of the lamp
beam passing through each filter had been previously deter¬
mined by Dr. E.R. Simpson (1967). This had been determined
using a Mullard photo-emissive cell with a type ,A* caesium-
antimony photocathode, connected to a Varian 33B-2 electro¬
meter.
The experimental procedure was exactly as described
for experiments on the carbon monoxide inhibition. However,
the enzyme preparation was the 103,000 g. x 60 min. supernatant
of a mitochondrial acetone powder suspension. The standard
cholesterol side-chain cleavage assay was used, except that the
final volume was halved i.e. 2*5 ml.} thus effectively doubling
the concentration of the reactants (see Table 3*1)• Light
passing through the appropriate filter illuminated the cuvette
and its contents during the 5 min. pre-incubation period
prior to the addition of the cholesterol. Gassing
of the cuvette contents continued throughout the experiment.
An initial experiment was carried out to determine
whether light from the lamp, in the absence of any filters,
was effective in reversing the carbon monoxide inhibition.
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Incubations were initially carried under a gas phase
composed of 10$ oxygen, 10$ carbon monoxide and 80$ nitrogen.
However, very little carbon monoxide inhibition of cholesterol
side-chain cleavage activity was detected. Prom the
previous investigations of the carbon monoxide sensitivity of
the enzyme system which gave a value near unity for the
Warburg partition constant between carbon monoxide and oxygen,
an approximately 50$ inhibition of the enzyme activity was
expected. The enzyme source in this study was a mitochon¬
drial acetone powder extract instead of the mitochondrial
sonicate preparation used in the earliercarbon monoxide
inhibition experiments and the acetone powder preparation
had a greater activity compared to the sonicate preparation.
This allowed a reduction in the assay period from 1 hour to
15 rains. Since assays could only be performed singly, this
facilitated more ideal experimental conditions. When the
carbon monoxide to oxygen ratio was increased, inhibition
of enzymic activity was observed. This problem will be
dealt with more fully in the Discussion.
Table 5«1 shows the results obtained in an experiment
outlined below.
Incubation(1) was conducted under a gas phase of 10$
oxygen, 90$ nitrpgen; incubations (2) and (3) were carried
out under a gas phase composed of 10$ oxygen, 40$ nitrogen
and 50$ carbon monoxide. Incubations (1) and (2) were
conducted in the dark while incubation (3) was carried out with
th e cell illuminated with the light beam from the Xenon lamp.
The results clearly demonstrate that the carbon monoxide
TABLE5.1
THELIGHTREVERSALOPCARBONMONOXIDEINH BITITCHOLESTEROLSID -CHAIN CLEAVAGEACTI ITYOPSO UBILISEDPLACENT LMIT CHO DRIAPREPAR TION IncubationNo.ConditionsPer ent geCo v rsion 1Dark2 *1 2Dark+COli^'6 3Light+CO19*7
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inhibition in the presence of oxygen was reversed by light.
The light beam caused no heating of the incubation medium so
that the observed reversal was not due to thermal effects.
Photochemical action spectrum
In this study three interference filters were used, with
transmission maxima at I4JL8, J4.I4.8 and l\.JO nm. The enzyme source
was the same preparation as for the previous experiment,
i.e. a 103,000 g. x 60 min. supernatant of a placental mito-
chontrial acetone powder suspension (equivalent to 30 mg.
mitochondrial powder per ml.). The incubation period was
again 15 minutes. One value of the enzymic activity was
obtained using each filter. Control incubations were also
conducted, namely an incubation in the presence of carbon
monoxide but in the absence of light and an incubation in
the absence of carbon monoxide. AK was calculated by sub¬
tracting the value of for the particular preparation from
the value of K-^ obtained for each filter. The final results
are expressed as the ratio -
AK
L
= 1lUl-8 . Kd
LIth8
Kd
The subscript hh8 refers to the value at I4I4.8 nm.
The results are set out in Table 5*2.
The relative light intensities determined for this
particular apparatus by Simpson (1967) are tabulated in
Table 3»3*
It can be seen that of the three wavelengths investigated
TABLE5.2
THELIGHTREVERSIBILITYOPTHECA BONMONOXIDEN I IT ONT ECHOL S ROLSID - CHAINLEAVAGEACTIVITYOPSOLUB LISEDPLACEN ALMI OCHO DRIALXTRACTUS GIGH OPDIFFERENTWAVELENGTHS I\—Klak7-^-(nm)rQ1L^q I4.I80*714-13- 02-50 2 I+I4.80-8731^-0022-71*0 1+700-7716-305*20-16 foreachdet rmination=11*3
TABLE5.3









light of 14^8 nra wavelength was the most effective in
reversing the carbon monoxide inhibition. The results
obtained for the placental cholesterol side-chain cleavage
enzyme system are very similar to those obtained for the
adrenal enzyme (Simpson and Boyd, 1967a) and other mixed-
function oxidases (e.g. Omura et al.» 1965)• This type of
result has been taken as strong evidence for the involvement
of cytochrome P-l|.50 as the site of oxygen binding in these
systems. One migjht conclude, therefore, that cytochrome
P-I4.50 is involved in oxygen activation in the placental
cholesterol side-chain cleavage enzyme system also.
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Studies on the resolution of the components of the
cholesterol side-chain cleavage system of human placenca
In 1957* Ryan and Engel observed that carbon monoxide
inhibited steroid 0-21 hydroxylation in adrenocortical
microsomes. Garfinkel (1958) and Klingenberg (1958),
working independently, discovered a carbon monoxide com¬
bining substance in liver microsomal preparations. This
was later shown to have cytochrome-like properties and was
subsequently termed cytochrome P-i|.50 (Omura and Sato,
1961^a, b). Early attempts to isolate components of steroid
hydroxylating systems showed the existence of at least three
proteins and an unknown heat stable factor (Tomkins et al.,
1958).
Studies on the steroid lip-hydroxylase of adrenal
cortex mitochondria (Omura et al., 1965; Omura et al., 1966;
Kimura and Suzuki, 1967) have shown that this system consists
of at least three protein fractions - a fraction containing
cytochrome P-l^.50, a flavoprotein dehydrogenase and a non-
haem iron protein, which upon recombination restored the
116-hydroxylase activity. Billiar and Little (1966, 1969)
observed that placental mitochondria contained a factor
which in the presence of specific adrenal mitochondrial
fractions could stimulate steroid 116-hydroxylation. The
factor corresponded to the adrenal non-haem iron protein,
adrenodoxin, but the factor appeared different to adreno-
doxin, although isolated by a similar method.
Gonstantopoulos and Tchen (1961) and Bryson and Kaiser
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(1962) resolved the cholesterol side-chain cleavage enzyme
into at least two protein fractions on the basis of ammonium
sulphate fractionation studies. Simpson and Boyd (1967b)
having earlier shown that the adrenal cholesterol side-chain
cleavage enzyme was similar to the steroid 113-hydroxylase,
displaying carbon monoxide sensitivity and the subsequent
reversal of the inhibition by light (Simpson and Boyd, 1966),
presented evidence for the existence of three protein compo¬
nents in the adrenal enzyme. These were, namely, a fraction
containing cytochrome P-I4.5O, a flavoprotein fraction together
with a non-haem iron protein (adrenodoxin). This latter
study emphasised the similarity between the steroid 113-hydroxy-
lase and the cholesterol side-chain cleavage enzyme.
Billiar and Little (1966, 1969) have shown that
placental mitochondria contain a factor which in the presence
of specific adrenal mitochondrial fractions can stimulate
113-hydroxylation although the placental mitochondria cannot
themselves catalyse 113-hydroxylation. similar observations
have been made with liver (Nakamura et al., 1965* 1966),
testis (Ohno et al., 1967; Kimura and Qhno, 1968) and ovarian
factors (Kimura and Ohno, 1968). The testicular protein
which stimulates 113-hydroxylation is similar to adrenodoxin
(Kimura and Ohno,(1968)). Adrenodoxin is a low molecular
weight protein which contains non-haem iron and acid-labile
sulphur and participates in the electron transfer from
NADPH and a flavoprotein (adrenodoxin reductase) to cyto¬
chrome P-I|.50 for steroid hydroxylation (Oraura et al., 1965).
However, Billiar and Little (1969) found that the placental
factor which stimulates 113-hydroxylation was different to
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adrenodoxin although Isolated by similar methods. Morrison
et al. (1965) attempted to resolve the cholesterol side-chain
cleavage enzyme present in a placental mitochondrial acetone
powder extract using Sephadex gel chromatography and ammonium
sulphate fractionation. However, loss of enzymic activity
after such procedures did not allow any conclusions to be
made about the enzymic system.
An attempt was therefore made to characterise the
protein components of the human placental cholesterol side-
chain cleavage enzyme system.
Fractionation of the 1solubilised1 enzyme using Sephadex G-200
The human placental cholesterol side-chain cleavage
enzyme was solubilised as previously described, i.e. 900 mg.
lyophilized mitochondria were suspended in 30 ml. 0-1 M
phosphate buffer (pH 7*14-) and centrifuged at 105*000 g.
for 60 minutes. The supernatant whih contained the
> enzymic activity was concentrated using Csrbowax 20 w (Union
Carbide Co.). The concentrated sample was applied on to a
Sephadex G-200 column which had been prepared as follows:
Sephadex G-200 was allowed to swell for 7 days in 0'1 M
phosphate buffer, pH 7*before use. A glass column
(35 cm. x 3 cm.) was filled with the Sephadex G-200 and
allowed to run overnight to enable settling and equilibration
of the gel. Elutlon was carried out using 0'1 M phosphate,
pH 7*i+« The eluate was monitored at 280 nm by means of an
L.K.B. 83OO A 'Uvicord II* absorptiometer and a 6520 H
recorder. The fraction collector was an L.K.B. 7000 A























5.5 Elution pattern of a lyophiliied placental
mitochondrial extract chroaatographed on
Sephadex G-200, shoving the distribution
of haea and non-haea iron.
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The first peak was shown to contain haem iron, the maximum
of which corresponded to the protein concentration maximum
(Pig. 5*5) • in. the Sephadex G-200 chromatography of the
solubilised adrenal and ovarian enzymes (Simpson and Boyd
(1967)J Suliraovici and Boyd, 1968) this first peak was found
to contain the cytochrome P-ij.50. In the present experiment,
although the fraction contained haem iron, no cytochrome
P-450 was detected. The carbon monoxide reduced difference
spectrum of the fraction did, however, show an absorption
at Ij20 nm, presumably cytochrome P-i4.20. The second protein
peak contained the relatively large amount of haemoglobin
which contaminated the solubilised enzyme and in fact, the
280 nm trace of this fraction appeared to reflect the
haemoglobin content of the preparation. The pooled
fractions I, II and III (see Pig. 5*5) were separately
concentrated using either "Carbowax" or lyophilization to
reduce the volumet. The fractions were then incubated in
the presence of an NADPH generating system with [14.-^0]
cholesterol using the normal assay procedure. The protein
concentration of each fraction corresponded to approximately
twice the protein concentration used in the standard assay.
It was seen (Table that optimal activity was obtained
when fraction I and II were present. Addition of fraction
III appeared to produce some inhibition of the cholesterol
side-chain cleavage activity. It was found, later that
when the enzyme preparation was dialyeed prior to application
on to the column, this third peak was no longer present.
This indicated that it consisted of low molecular weight
TABLE5.1i.













5*6 Elution pattern of 2nd pooled fraction (see
'ig* 5*5) on DEAE-Sephade* (A-25)> shoving
the distribution of JfADPil di&phoraae and
non-haea iron.
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material, possibly polynucleotide phosphates.
Separation on DEAE-Sephadex.
The pooled fraction II after Sephadex G-200 chromato¬
graphy was applied on to a DEAE-Sephadex column (25 cm. x
2*5 cm.). The column was equilibrated with O'Oij. M phosphate
buffer pH 7'ij- and elution was carried out utilizing a salt
(sodium chloride) gradient up to 0*7 M. using a flow rate of
40 ml. per hour. Figure 5*6 shows a typical 280 nm.
elution traoe after such chromatography. The initial
fraction. Which was eluted with O'Oij. M phosphate buffer,
exhibited NADPH-diaphorase activity - indicative of the
presence of a flavoprotein. However, the major component
of the fraction was haemoglobin. The second ma^or fraction
which was eluted at high salt concentration (0*7 M NaCl)
contained non-haem iron. This fraction was not apparently
eluted as a single component. Comparison of the E2g0 trace
and the non-haem iron estimations revealed that the non-haem
iron containing component was eluted in the front portion
of the fraction.
Non-haem and haem iron estimations were carried out
as described in Chapter 2.
NADPH diaphorase activity was estimated by a modification
of the prooedure of Omura et al. (1966). To 1*5 ml. aliquots
were added 0*2 ml. NADPH generator system (3*7 mg. NADP+,
12*5 nig. gluoose-6-phosphate and 1 l.u. gluoose-6-phosphate
dehydrogenase per ml. water). After 2 minutes 0*2 ml. of
an aqueous solution (0*3 mg./ml) of 2:6 dichlorophenol
indophenol (DCPIP) was added. The decrease in absorbancy
at 590 nm. was followed.
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The elution patterns obtained on both Sephadex G-200
and DEAE-Sephadex chromatography were very similar to those
obtained by Omura et al. (1966) and by Simpson and Boyd (1967)
after similar chromatography of adrenal mitochondrial acetone
powder extracts. Sulimovici and Boyd (1968) also achieved
a similar fractionation of a rat ovarian mitochondrial
extract.
The NADPH-diaphorase (flavoprotein) fraction and
the non-haem iron protein fraction were dialysed against
O'Oij. M phosphate for 3 hours (3 changes of the dialysing
buffer) and then concentrated using "Carbowax". The
three fractions, i.e. the haem-containing fraction, the flavo¬
protein and the non-haem iron protein, were incubated
individually and collectively with [lj.-"^c] cholesterol em¬
ploying the normal assay procedure. Cholesterol side-chain
cleavage activity was only observed when all three components
were present. However, the activity observed compared to
the unfractionated enzyme was minimal. The results are
presented in Table 5»5* It appeared that DEAE-Sephadex
Chromatography was harmful to one or both of the protein
components. Cooper et al. (1968) have also observed that
for maximal activity after fractionation of the steroid 110-
hydroxylase, relatively larger molar amounts of non-haem iron
protein compared to the other two components were required.
It is, therefore, possible that limiting amounts of placental
non-haem iron protein were present in the reconstituted
system.
TABLE5.5
REGONSTITOTIONOFCHOLE TEROLSIDE-CHAINLEAVAGEA TIVI YTS UBILIS D ENZYMEAFTERCHROMATOGRAPHYONS PHADEXG-200DEAE-SEPHADE FractionPercentageConversion I0*2 NADPHdiaphoraae(Fp)0*2 Non-haemir nprotein( HIP)0*3 I+Fp0-2 I+NHIP2'3 F+NHIP0*3 * I+FpNHIP3*5 Eachfractionwaspresentinnmountequival tto60mg.lyophilizedmit chondria
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Characterisation of the protein components
Cytochrome P-H50. Fraction I after Sephadex G-200 chroma¬
tography contained a haemoprotein. The carbon monoxide
reduced difference spectrum - the common method of showing
the presence of cytochrome P-ij.50, revealed an absorption
band at 1(20 nm. This absorption was due either to the
presence of cytochrome P-I42O - the inactive form of cytochrome
P-U50 - or to the presence of contaminating haemoglobin, the
bulk of this major contaminant of the enzyme preparation being
found in fraction II. Due to the small size of this
absorption band, one could not distinguish between the two
possibilities using the usual method i.e. formation of the
cyanide complex. Thus cytochrome P-I4.5O could not be
identified in the high molecular weight fraction i.e.
fraction I, where, by analogy with the adrenal and ovarian
enzymes, it should be located. However, it was shown earlier
in this chapter that the enzyme preparation prior to
fractionation contained very low amounts of cytochrome P-J+SO.
A small conversion of this cytochrome P-^50 to cytochrome
P-1420 during chromatography could reduce the cytochrome P-45O
content to an undetectable level.
Flavoprotein. After DEAE-Sephadex chromatography, a fraction
was obtained of which the major component was haemoglobin.
The fraction, however, exhibited NADPH-DCPIP reductase
activity - characteristic of a flavoprotein. It was not
possible to separate the flavoprotein activity from haemoglobin.
The cholesterol side-chain cleavage activity had an absolute
requirement for this fraction.
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Non-haem Iron protein. Kimura and Suzuki (1965) and Suzuki
and Kimura (1965) in studies on pig adrenal steroid hydroxy¬
lases identified a non-haem iron protein as one of the
components involved in the electron transfer system associated
with the steroid lip- hydroxylase activity of the mito¬
chondria. This fraction was named •adrenodoxin*. It was
found to possess similar physical and chemical properties to
the plant ferredoxins, i.e. it contained non-haem iron and
labile sulphur-containing groups. The redox potential of
adrenodoxin was, however, higher than that of, say, spinach
ferredoxin (approximately zero compared to -0• L±3 volt).
Simpson and Boyd (1967b) demonstrated that adrenodoxin was
also involved in the cholesterol side-chain cleavage reaction
occurring in adrenal mitochondria. Ohno, Suzuki and Kimura
(1967) have also isolated and identified a non-haem iron
protein from pig testis similar to adrenodoxin and proposed
the name of testodoxin.
In the present study it has been possible to show the
presence of a non-haem iron protein in human placental mito¬
chondria. The protein has similar chromatographic properties
to adrenodoxin and appears to be involved in the cholesterol
side-chain cleavage enzyme system. Billiar and Little (1969)
have recently isolated a non-haem iron protein from placental
mitochondria, which stimulated adrenal steroid 113-hydroxylase
activity. These workers, however, reported that the placental
non-haem iron protein differed from adrenodoxin and testo¬
doxin in that the labile inorganic sulphide content was very
low compared to the non-haem iron content. The placental
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protein, they suggest, is more similar to the liver factor
that can stimulate adrenal steroid 110-hydroxylase (Nakamura
et al., 1966). Liver does not appear to contain a protein
similar to adrenodoxin (Kimura and Ohno, 1968). Kimura and Ohno
(1968) have suggested that tissue extracts with low ratios
of acid-labile sulphur to non-haem iron do not contain
proteins similar to adrenodoxin.
In the present study, the non-haem iron and acid-labile
sulphur contents of the placental non-haera iron protein
fraction eluted from the DEAE-Sephadex column were estimated
as described in Chapter 2. Protein determinations were
carried out according to Lowry et al. (1951)* The non-haem
iron content was estimated to be 80 n atoms per mg. protein
while the labile sulphur content was I4.0 nmoles per mg.
protein. Kimura (1968) has reported that 1adrenodoxin1
contains 109 n atoms of iron per mg. protein and 100 nmoles
labile sulphur per mg. protein, i.e. a non-haem iron to
labile sulphur ratio of approximately unity. The placental
non-haem iron protein has a non-haem iron to labile sulphur
ratio of 2. The lower non-haem iron content of the placental
protein is probably due to the fact that Kimura's adrenodoxin
preparation had undergone further purification procedures.
However, the much lower labile sulphur content is either a
characteristic of the placental protein or that some labile
sulphur has been shed during the fractionation procedures.
The purity of the placental non-haem iron protein was
examined using acrylamide gel disc electrophoresis, but
due to the small amount of a rather dilute sample being
available, the results were not conclusive.
9k
Distribution of the 3P-hydroxysteroid dehydrogenase-isomerase
system after Sephadex G-200 chromatography.
The 105,000 g. - 60 min. supernatant extracts of lyo-
philized placental mitochondria contained appreciable 33-
hydroxysteroid dehydrogenase-isomerase activity. The
various fractions obtained after Sephadex G-200 chromatography
of such extracts were examined in order to determine the
location of the dehydrogenase enzyme system. The assay
consisted of the incubation of various fractions with [14.-^0]
pregnenolone in the presence of NAD+ (0*2 mg./5 ml. incubation).
The incubation period was 15 minutes. The remainder of the
assay procedure was as described in Chapter 2. The results
are presented in Table 5-6. The highest dehydrogenase
activity was located in fraction I. Thus the dehydrogenase-
isomerase system appeared to be associated with the high
molecular weight material. This finding implies that the
dehydrogenase system is closely associated with the cholesterol
side-chain cleavage enzyme system, i.e. the possible existence
of a mitochondrial 30-hydroxysteroid dehydrogenase-isomerase
enzyme system. The enzyme is usually said to be located
only in the microsomal fraction. However, Koide and
Torres (1965) have presented evidence for the presence of
separate mitochondrial and microsomal 33-hydroxysteroid
dehydrogenase-isomerase systems in adrenal tissue. Thus
placental mitochondria are possibly capable of converting
cholesterol to progesterone before release of the latter
from the mitochondria.
TABLE5.6
DISTRIBUTIONOP33-HYD OXTS EROIDDEHYDROGENASE-ISOMERASEAC V YFT CHROMATOGRAPHYOPTHESOLUBILISEDMITOCHONDRIALPREPARATIONSE A EXG-200 %Conversionf[lj.-^^'C]Pregnenolonet "^C-Progesterone
9*7 0-7





The particular mammalian sterol raono-oxygenase
investigated in this study has been the cholesterol side-
chain cleavage enzyme system of human term placenta. The
work of Halkerston et al. (1961) and later ghimizu (1968)
has shown that the adrenal enzyme has a requirement for
molecular oxygen and NADPH. It thus satisfies the criterion
to be classified as a mixed-function oxidase, as defined by
Mason (1957) •
The side-chain cleavage of cholesterol is the first
step in the degradation of this substance to steroid hormones
by endocrine tissue. There is evidence that the initial
20a-hydroxylation of cholesterol is the first step in the
reaction and it is thought to be the rate limiting step in
steroid hormone biosynthesis, possibly controlled by trophic
hormones (Stone and Hechter, 195i+) • The cholesterol side-
chain cleavage enzyme system has been most extensively studied
in adrenocortical tissue and to a lesser extent in ovarian
and testicular tissue (see Sulimovici and Boyd, 1969b, for
a review of earlier studies).
Earlier studies on the cholesterol side-chain cleavage
in other tissues were hampered by the lack of a suitable
assay. Two methods have been used, in general - estimation
of the 0^ fragment, isocaproic acid (Ichii et al., 1963) or
measurement of pregnenolone, the first C^ steroid product
of the cleavage reaction (Hall and Koritz, 1962+). The
first method had the disadvantage that it yielded no infor¬
mation on the nature of the steroid produced in the reaction,
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while the second assumed that pregnenolone was the sole
product of the reaction, which is not always the case. These
problems were largely overcome by the use of labelled
cholesterol as substrate coupled with the use of thin-layer
chromatography for the separation of the substrate and
products. Rsdio-chromatogram scanning and liquid scintillation
spectrometry were the procedures used to detect and quantitate
the products. Such an assay, which had been developed in
this laboratory (Simpson, 1967) was found to be rapid,
reproducible and sensitive allowing the detection of meta¬
bolites which might occur in small amounts.
Using such an assay technique, when mitochondrial and
microsomal preparations obtained from placental homogenates
were incubated with [ij.-"^c] cholesterol as jubstrate in the
presence of an NADPH generating system, cholesterol side-chain
cleavage activity was observed only in the mitochondrial
fraction (Table 3.2). This observation was in agreement
with other studies of the cholesterol side-chain cleavage
reaction in other endocrine tissues (Sulimovici and Boyd,
1969b).
Using the "normal" assay concentration of the NADPH
generating system (1 mM), which gave maximal metabolite
production, the only product detected was [^C] progesterone.
The identity of this steroid product was confirmed by thin-
layer chromatography in other solvent systems and radio-GLJ
chromatography. In all instances the radioactive material
chromatographed with progesterone. The percentage con¬
version of the tracer cholesterol to progesterone was between
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h and 10% in a one hour incubation. The activity varied
from one preparation to the next (Table 3.2). These
activities were therefore about ten-fold higher than those
previously observed by Ryan ete al. (1966). These workers
observed a Q'6% conversion in one hour, but used a much lower
concentration of the NADPH generating system (5 pM). That
progesterone was the major metabolite of the cholesterol side-
chain cleavage reaction was in some ways surprising. While
it is well known that the placenta contains a very active
-hydroxysteroid dehydrogenase-isomerase enzyme system
capable of converting pregnenolone to progesterone, it is
usually assumed to be a microsomal enzyme. However, repeated
washing of the mitochondrial fraction did not influence the
nature of the reaction product. This observation is
therefore in agreement with that of Koide and Torres(1965)
who reported that the dehydrogenase-isomerase enzyme appeared
to be associated with both the mitochondrial and microsomal
material. Sulimovici and Boyd (1969a) have reported the
existence of distinct dehydrogenase-isomerase enzymes in
immature rat ovarian mitochondria and microsomes. How¬
ever, it was possible that in this study, the mitochondrial
fraction was contaminated with microsomes, even though the
mitochondria were subjected to repeated washing. Electron-
microscopic examination of the mitochondrial fraction re¬
vealed that the preparation was essentially mitochondrial,
although some endoplasmic reticulum was present (Fig. 3.1).
Most of the mitochondria appeared damaged, presumably caused
by the homogenisation procedure.
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Despite the fact that intact mitochondria are not
permeable to pyridine nucleotides, it was observed that
the placental mitochondrial cholesterol side-chain cleavage
enzyme system required NADPH supplied by the NADPH gener¬
ating system. In these studies, the NADPH was, of course,
generated extramitochondrially. Yago and Ichii (1969) have
observed that the cholesterol side-chain cleavage enzyme of
adrenocortical mitochondria is located in the inner mito¬
chondrial membrane. Thus, presumably NADPH has to permeate
to the inner membrane in order that it might be utilized.
T;he results obtained demonstrate that the placental mito¬
chondrial preparation did not consist of intact mitochondria,
and were in fact •leaky* mitochondria. The preparation of
*good* mitochondria is a problem when dealing with placental
tissue. The presence of large amounts of vascular and
connective tissue does not permit the use of gentle homo-
genisatlon techniques that are used, for example, in the
preparation of liver mitochondria.
Since glucose-6-phosphate dehydrogenase is not a mito¬
chondrial aizyme, the physiological supply of NADPH must
arise from some other source. Using bovine adrenocortical
mitochondrial preparations, Simpson and Estabrook (1969)
have shown that the NADPH required for steroid llp-hydroxy-
lation arises from malate via mitochondrial "malic enzyme".
These workers have found a quantitative relationship between
pyruvate production from malate and corticosterone output by
adrenal cortex mitochondria. When placental mitochondria
were incubated with 10 mM malate and NADP+ no cholesterol
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side-chain cleavage activity was observed (Table 3»3)»
Thus placental mitochondria do not appear to possess a mito¬
chondrial raalie enzyme, or at least if it is present, it does
not supply the NADPH for the cholesterol side-chain cleavage
reaction. Simpson (personal communication) has observed
virtually no malic enzyme activity in human placental mito¬
chondria. The other favoured mechanism for the supply of
intramitochondrial NADPH involves the pyridine nucleotide
transhydrogenase, an energy requiring process. Peron and
coworkers (see Peron et al.,1966) favour this process as
the important source of NADPH in rat adrenal mitochondria.
When placental mitochondria were incubated with succinate,
malate and furanrate in separate incubations, cholesterol
side-chain cleavage activity was only observed using succinate
as the oxidisable substrate (Table 3.3)* It was also
observed that the product obtained when the reducing equiva¬
lents were supplied from succinate was pregnenolone, and not
progesterone. It is possible that the oxidation of succinate
resulted in the reduction of the endogenous NAD+ within the
mitochondria using reversed electron flow, and so removed the
cofactor for the dehydrogenase reaction. Transhydrogenation
from NADH to NADPH could then'occur and thus supply the NADPH
required for the hydroxylation reaction. The scheme is set
out below:- ^ ROii
NADPH —> —♦ NHIP —> cyt .P-J4.50
AI 02 H20
NADH fp^ Ubiquinone t 0yt._^ cyt.__^ cyt 0
cyt.b oj 0 a 3
Succ inat
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Malate could similarly be expected to supply NAEH via malic
dehydrogenase, but the results do not show this. One must
remember, however, that the placental mitochondria are pro¬
bably not intact i.e. are "leaky", with the possible resultant
loss of mitochondrial matrix enzymes as well as substrates and
cofactors. Succinic dehydrogenase is a membrane-bound
enzyme Whereas the other iCrebs' tricarboxylic acid cycle
enaymes are more soluble.
A further possible source of intramitochondrial NADPH
investigated was the action of mitochondrial NADP+-linked
isocitrate dehydrogenase. When cholesterol side-chain
cleavage assays were carried out using placental mitochondria
and isocitrate (3 mM), cholesterol side-chain cleavage
activity was observed (Table 3*3)» However, isocitrate was
not as good an electron donor as was succinate. But,
the mitochondrial NADP+-linked isocitrate dehydrogenase-
catalysed reaction could act as a source of reducing equi¬
valents in human placental mitochondria. Schreiner and
Villee (1963) observed that mitochondria from full term
placentae were more uncoupled than mitochondria from 3 month
placentae, i.e. had a much higher 0^ consumption. Since the
progesterone content of the full term placentae was approx¬
imately twice that of the 3 month ones, a relationship
between the degree of uncoupling and the progesterone content
was suggested. It is possible that during maturation of
the placenta, reducing power from oxidisable substrates is
redirected from the normal respiratory electron transport
system to the electron transport system involved in hydroxy-
lation reactions. A further result that suggested the
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existence of a system in placental mitochondria capable of
transferring reducing equivalents between NAD and NADP, i.e.
NAD+ + NADPH ^ NADH + NADP+
- was that further increase of the NADPH level resulted in an
accumulation of pregnenolone, although the overall cholesterol
side-chain cleavage activity was not significantly affected
(Table 3.i^). This can be explained if the excess NADPH
could reduce the endogenous NAD+ required for the dehydro-
genation of pregnenolone. The results obtained in this
study favour a transhydrogenase system as the source of the
mitochondrial NADPH required for mixed-function oxygenation
reactions rather than a mechanism involving malic enzyme.
However, it must be mentioned that isocitrate, coupled
presumably with endogenous isocitrate dehydrogenase, was
also capable of supplying NADPH for the placental cholesterol
side-chain cleavage enzyme. Therefore it is equally possible
that mechanisms not involving a transhydrogenase are
important in placental mitochondrial NADPH generation. No
direct evidence for a placental mitochondrial pyridine
nucleotide transhydrogenase exists, although the soluble
placental transhydrogenase, involving catalytic amounts of
oestradiol and oestrone, has been well documented (see
Jarabak, 1969).
Yago, Dorfman and Forchielli (1967) demonstrated that
exogenously added NADPH was not oxidised by a "heavy mito¬
chondrial" preparation of bovine corpora lutea. Extramito-
chondrial NADPH was also found to be a poor electron donor
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for the mitochondrial 113-hydroxylase of rat adrenal
(Harding et al., 1965; Peron et al., 1966). Earlier
studies on liver and heart mitochondrial respiration showed
that external nicotinamide nucleotides were not utilised
at appreciable rates (Lehninger, 1951; Ghance and Williams,
1955; Lehninger et al., I960). Koritz (1968) observed
that addition of Ca++ ions, a known mitochondrial swelling
agent, greatly enhanced the cholesterol side-chain cleavage
activity of rat adrenal mitochondria in the presence of
exogenous NADPH. The stimulated activity was attributed
to the easier penetration of the NADPH into the swollen
mitochondria. The accessibility of NADPH to the cholesterol
side-chain cleavage enzyme could thus be an important
controlling factor, especially since the results of Yago
and Ichii (1969) indicate that in bovine adrenocortical
mitochondria, the enzyme is located in the inner mitochondrial
membrane.
When agents such as glutathione (GSH), cysteine known
to produce mitochondrial swelling were added to placental
mitochondrial preparations, no marked stimulation of
cholesterol side-chain oleavage activity was observed.
Glutathione, in small amounts, produced some activation of
the enzymic activity, whereas higher concentrations of the
reducing agent inhibited the enzyme system (Pig. ij..7) • Cys¬
teine did not produce any observable effect on the enzymic
activity, whereas 3-mercapto-ethylamine inhibited the enzyme
(Pigs. J4..5 and I4..6). It must, however, be remembered that
the placental cholesterol side-chain cleavage enzyme responded
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to extramitochondrial NADPH in the absence of a known
swelling agent. Thus it is likely that the mitochondria
were in a swollen state prior to addition of the swelling
agents.
In order to study the components of the cholesterol
side-chain cleavage enzyme system present in human placental
mitochondria, it was desirable to 'solubilise' the enzyme
system. * Solubilisation' was loosely defined as the
presence of enzymic activity in the supernatant after high¬
speed centrifugation at 105,000 g. for 30 minutes in a
medium of 0*1 M KCl or 0*1 M phosphate buffer. It was purely
an operational definition, implying that the enzyme was in
a form amenable to some preliminary fractionation studies.
Three techniques which had previously bem used to
solubilise the enzyme system in other tissues were all
successfully used. Ultrasonication (Simpson and Boyd, 1966)
of a placental mitochondrial suspension in water followed by
centrifugation at 105,000 g. for one hour resulted in
enzymic activity being located in the high-speed supernatant
(Table 3.5)• Similarly, after lyophilization of the mito¬
chondrial sonicate, the lyophilized mitochondria could be
suspended in 0*1 M KCl or 0*1 M phosphate buffer, pH 7'k»
to yield a supernatant after high-speed centrifugation which
had cholesterol side-chain cleavage activity (Table 3*&)»
Mitochondrial acetone powder preparations also yielded active
'soluble* enzyme preparations (Table 3.7)* in agreement with
the previous report of Morrison et al. (1965). The major
product detected when these solubilised preparations were
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incubated with cholesterol was pregnenolone, with
smaller amounts of progesterone being found. It appeared
that most of the 33-hydroxysteroid dehydrogenase remained
associated with the particulate material (Table 3.10).
During the procedure of preparing the solubilised
enzyme system it was found that whereas the native mitochon¬
drial preparations had demonstrable cholesterol side-chain
cleavage activity, the same preparations after ultrasoni-
cation or lyophilization appeared to have lost this enzymic
activity (Tables 3«5» 3*6 and 3*7). However, after higjh
speed centrifugation of the sonicated or lyophilized pre¬
paration enhanced enzymic activity was found in the super¬
natant. Addition of the high speed (103,000 g. x 60 min.)
lyophilized mitochondrial pellet to the supernatant com¬
pletely inhibited the enzymic activity (Table 3.6). Thus
the particulate material appeared to contain a substance (or
substances) inhibitory to the cholesterol side-chain cleavage
activity. This finding was contrary to that observed during
the solubilisatlon of the enzyme from immature rat ovarian
and bovine adrenocortical mitochondria (sulimovici and Boyd,
1969b; Simpson, 1967). These workers found that disruption
of the mitochondria by such procedures as ultrasonication and
lyophilization resulted in enhanced cholesterol side-chain
cleavage activity. It was thought initially that the
inhibitory substance could be endogenous cholesterol. In
the native placental mitochondrial preparations it might be
proposed that the added [I4.—J cholesterol does not equili-
105
brate with the total mitochondrial cholesterol ■ and
preferentially equilibrates with the "steroidogenic
cholesterol pool". One must assume that the mitochondrial
cholesterol available for steroidogenesis is a small part
of the total cholesterol of the mitochondria. Evidence
for this assumption was obtained by Armstrong et al. (196ij.)
from experiments in which acetate or mevalonate were found
to be better precursors (on the basis of specific activity
determinations) for steroid biosynthesis than was cholesterol.
However, cholesterol was found to be intimately associated
with steroidogenesis and hence the postulation of a "steroid¬
ogenic pool" of cholesterol. Upon disruption of the mito¬
chondria by ultrasonication or lyophilization, it might then
be assumed that the tracer cholesterol could equilibrate
with a much larger pool of cholesterol. This would result
in a very effective dilution of the tracer cholesterol and
an apparent inhibition of the cholesterol side-chain cleavage
activity as assayed in this study.
However, when experiments were carried out to study the
effect of amounts of cholesterol normally expected to be found
in mitochondrial preparations (approximately 10 jig. per mg.
, O * T~h
lyophilized mitochondria) on the apparent cholesterol side-chain
Aj
cleavage activity, considerable enzymio activity was observed
at exogenous cholesterol levels of I4.OO j±g. per incubation
(Table 3*12). The total cholesterol content in lyo¬
philized placental mitochondria is certainly less than I4.OO jig.
This experiment can be criticised because the exogenous
cholesterol was added in the free form in acetone, whereas
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the endogenous cholesterol is undoubtedly bound in some
form of lipoprotein structure.
The experiment also permitted an estimate of the
apparent of the enzyme for the cholesterol substrate
(Fig. 3*7)* The apparent varied between 50 and 200 pM
depending on the particular solubilised mitochondrial pre¬
paration. There are obviously non-specific cholesterol
binding sites as well as the binding site on the enzyme.
The number of these non-specific sites presumably varies
from one solubilised preparation to the next. Raggatt and
Whitehouse (1966) obtained an apparent for the adreno¬
cortical enzyme of about 5° pM but these workers also
observed considerable variations in the value obtained.
Young and Hall (1969) have recently obtained an apparent
of I4.O-5O pM for the adrenal enzyme.
Evidence was obtained for the lipid character of the
inhibitory substance. It was heat stable (Table 3.8) and
could be extracted from the particulate material using the
general lipid solvent, chloroform-methanol (2:1, v/v)
(Fig. 3.5) while it was not extractable using a hot aqueous
solution (Table 3.8). Thrther evidence for the lipid nature
of the inhibitor was from observations on the preparation
of placental mitochondrial acetone powders. It was found
that a long exposure (10-15 minutes) of the mitochondria to
acetone resulted in the removal of the inhibitory material
(Table 3.10). This observation was indicative of the
removal of lipid(s) from the mitochondria.
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Examination of the chloroform-methanol extracts
of the 105»000 g. x 60 min. pellet from lyophilized mito¬
chondrial suspensions using thin-layer chromatography re¬
vealed that the main components present were phospholipids
and cholesterol and the most inhibitory fraction was the
phospholipid (Table 3.9). The phospholipid fraction was
further resolved into phosphatidyl choline (lecithin),
phosphatidyl ethanolamine and probably cardiolipln. The
lecithin fraction was the most inhibitory (Pig. 3.6.).
The acetone wash after the preparation of mitochondrial
acetone powders was also found to be inhibitory (Table 3*H)«
TLG examination of the acetone wash revealed that the com¬
ponents present were phosphatidyl ethanolamine, lecithin,
cardiolipin and cholesterol.
It appeared, therefore, that the observed inhibition
in sonicated and lyophilized mitochondrial suspensions was
due to the mitochondrial phospholipid, especially lecithin.
In order to study the effect of phospholipids more
clearly, cholesterol side-chain cleavage assays (using a
105,000 g. x 60 min. mitochondrial acetone powder supernatant)
were performed in the presence of varying amounts of
commercially available highly purified lecithin and phospha¬
tidyl ethanolamine (Pig. 3.8). Lecithin was seen to be a
strong inhibitor of the cholesterol side-chain cleavage
enzyme at a concentration close to the phospholipid content
of mitochondria, i.e. about 30$ of the dry mitochondrial
weight (Rouser et al., 1968). Phosphatidyl ethanolamine was
a less potent inhibitor of the cholesterol side-chain cleavage
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activity, and at low concentrations (0*1 - 0*5 mM) stimulated
the enzymic activity.
Comparison of Pigs. 3.8 and 3.9b showed that the
inhibitory substance of the lyophilized mitochondrial
103,000 g. pellet and lecithin had similar inhibitory
effects on the enzymic activity. The inhibitor character¬
istic, K^, for the inhibitor from lyophilized mitochondria
was not determined due to the difficulty of estimating the
amount of endogenous "steroidogenic" cholesterol present in
the 105,000 g. mitochondrial pellet.
It was thought possible that the mitochondrial phospho¬
lipid might be exerting its inhibitory effect by sequestering
the added cholesterol into a form which could not be metabo¬
lised by the enzyme. However, a plot of I versus ^ ^ ^
where I was the inhibitor concentration and i was the
fractional Inhibition (1 - Mas found
to be a straight line (Pig. ^.11). This result, according
to Reiner (1969), is indicative of an involvement of the
enzyme in the inhibition to form an inhibitor-nubstrate-enzyme
inactive complex and not simply an inhibitor-substrate in¬
active complex. The straight line plot was obtained with
both lyophilized mitochondrial pellet and pure lecithin as
the inhibitor. It is possible that mitochondrial phospho¬
lipid, and cholesterol could form a 'lipoprotein" state to¬
gether with the enzyme, but the cholesterol is in a form
that is not metabolised.
The formation of a lipoprotein form of complex would
also provide an explanation of the differences observed
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between the placental and adrenocortical enzymes when the
mitochondria are disrupted and subjected to ultrasonication
or lyophilization. In the adrenal mitochondria, disruption
results in an enhanced cholesterol side-chain cleavage
activity (Simpson, 1967) while the present study has shown
disruption of placental mitochondria results in an apparent
inhibition of the enzymic activity. The formation of a
"lipoprotein complex" requires the presence of critical
concentrations of the complex components. If any component
is present in excess of the critical complex concentration,
then the component will not be found in a complexed form.
One major difference between the adrenal and placental mito¬
chondria is likely to be their respective cholesterol side-
chain cleavage enzyme contents, since adrenocortical mito¬
chondria contain much more of the enzyme based on the mito¬
chondrial cytochrome P-450 content. This present study
(Pig. 5»1)» as well as that of Meigs and Ryan (1968), has
shown that the absolute amounts of cytochrome P-I{.50 in
placental mitochondria are approximately one tenth those
calculated from data on adrenal mitochondria (Harding and
Nelson, 1966). Accepting that cytochrome P-450 is involved
in the cholesterol side-chain cleavage enzyme, the cyto¬
chrome P-ij.50 content might be taken as an approximate index
of the enzyme content. It might then be argued that the
placental enzyme concentration is close to the critical
complex concentration while the adrenal enzyme concentration
is much greater (ten t im e s) the critical concentration.
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Evidence for this concept was obtained in two experiments,
both employing lyophllized adrenocortical mitochondria.
The 105,000 g. x 30 rain, supernatant and pellet of the
lyophilized adrenal mitochondria were obtained in the normal
manner. After inactivation by heating of the residual activity
of the pellet, the effect of varying amounts of the pellet on
the cholesterol side-chain cleavage activity of the super¬
natant was studied. The latter contains only a small
proportion of the total mitochondrial cholesterol side-chain
cleavage activity (Simpson, 1967)• The pellet material was
found to be inhibitory (Table 3.11+). The second experiment
was to investigate the effect of pure lecithin on the
cholesterol side-chain cleavage activity of the adrenal mito¬
chondrial 105,000 g. supernatant (Pig. 3-.10). Lecithin
was found to inhibit the solubilised adrenal enzyme, just
as it did the solubilised plaoental enzyme. It therefore
seems likely the ratio of phospholipid to the enzyme is
critical for the observation of the enzymic inhibition.
(toe of the simplest explanations would be the formation of
an enzymatically inactive complex composed of enzyme,
phospholipid and cholesterol, with only a limited amount of
enzyme being taken into the micellar phase.
It has been established that mitochondrial phospho¬
lipid, especially lecithin, can inhibit the solubilised
cholesterol side-chain cleavage activity of placental mito¬
chondria at concentrations similar to those present in the
native mitochondria. However, this inhibition is very un¬
likely to be of physiological significance since intact
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mitochondria have a very organised structure, giving an
environment completely unlike that in the enzymic assay.
This is emphasised by the observation that native mito¬
chondria display cholesterol side-chain cleavage aotivity,
which is apparently inhibited when the mitochondrial structure
is disrupted by such processes as ultrasonication or lyo-
philization.
A similar inhibitory effect was observed by Sharma
et al., (1962) during attempts to solubilise the steroid
113-hydroxylase of adrenocortical mitochondria. After ultra-
sonication of the mitochondria, steroid 110-hydroxylase
activity could not be demonstrated until high speed centri-
fugation of the sonicate had been performed. The resulting
particulate material was found to be inhibitory. This
suggested the presence of an 110-hydroxylase inhibitor
associated with the insoluble particles. However, this
observation was not further investigated.
In summary, it appears that after disruption of
the placental mitochondrial structure, the endogenous phospho¬
lipid, especially lecithin, inhibits the cholesterol side-
chain cleavage activity. It is of interest since phospholipid
appears to be important for the activity of other steroid
and fatty acid hydroxylases (Williamson and O'Donnell, 1969J
Lu et al., 1969). The phospholipid could be important in
the interaction between the lipophilic substrates and the
enzyme protein. In the disrupted mitochondrial system, the
mitochondrial phospholipid bulk could very feasibly interfere
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In the interaction between the enzyme and the substrate,
especially when the enzyme content is very low.
Chapters 1+ and 5 are concerned with studies performed
on the solubilised cholesterol side-chain cleavage enzyme
of human placental mitochondria with regard to its pro¬
perties and characteristics. In all the studies discussed,
the solubilised enzyme system was obtained by ultracentri-
fugation at 105,000 g. for 60 min. of ultrasonicated, lyo-
philized or acetone powder suspensions (in 0*1 M KCl or 0»1 M
phosphate buffer pH 7 * It-) of placental mitochondria. The
acetone powder preparations generally gave the most active
systems, presumably due to removal of l endogenous cholesterol.
Mono-oxygenases require a source of reducing equiva¬
lents, usually either NADPH or NADH (Mason, 1965)* The
placental mitochondrial cholesterol side-chain cleavage
enzyme, in common with other mammalian steroid mono-oxygenases,
was found to have a specific requirements for NADPH. The
of the enzyme for NADPH was found to be about ljaM (Pig. ij..2).
Concentrations of NADPH from 2-500 pM produced very little
change in the enzymic activity. NADH (1 mM) did not support
any detectable cholesterol side-chain cleavage activity.
Satoh et al. (1966) found the optimal concentration of NADPH
for the adrenal cholesterol side-chain cleavage enzyme to be
about 50 nM. Boyd (1970) reported the of NADPH for the
liver microsomal cholesterol 7o-hydroxylase to be 300 jiM.
However this was in a crude microsomal preparation where there
are undoubtedly other NADPH oxidising systems.
It might be noted that recently Sih (1969) has produced
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evidence to support the concept that NADH can replace
NADPH as the reductant for the flavoprotein-adrenodoxin
reductase but much higher concentrations of NADH are required;
the being much larger. However, his postulated mechanism
for steroid llji-hydroxylation still has an absolute require¬
ment for NADPH to provide reducing equivalents to keep the
autoxidisable cytochrome P-450-Fe(II) in the ferrous state
of oxidation, a course which does not enter into the stoichio-
metry of the hydroxylation reaction. In the present study no
evidence was obtained to support the type of mechanism
suggested by Sih for enzymic hydroxylation reactions.
The pH-aotivity profile showed a broad maximal activity
in the pH region 6'8-7*6 (Fig. 4.1). The profile was veiy
similar to those obtained for the cholesterol side-chain
cleavage enzyme of rat ovarian mitochondria (Sulimovici,
1968) and the liver microsomal cholesterol 7a-hydroxylase
(Scholan, 1969).
Increasing buffer concentration was found to have a
marked inhibitory effect on the cholesterol side-chain
cleavage activity (Fig. 4*3)* Phosphate at a concentration
of 200 mM completely abolished the enzymic activity. Satoh
et al. (1966) had previously observed that the conversion of
cholesterol to pregnenolone in bovine adrenal cortex mito¬
chondria was greatly stimulated by inorganic phosphate; the
optimal concentration was about 10 mM. Higher concentrations
of inorganic phosphate were found by these workers to be
inhibitory and 100 raM phosphate produced essentially complete
inhibition. The placental enzyme, therefore, appeared to
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be similarly affected by the presence of phosphate as was
the adrenal enzyme. However, the very low concentration
effect of phosphate was not studied due to problems of
the buffering power. The inhibitory effect of phosphate
was found not to be specific since other buffer salts
(Tris-HCl, citrate, glycylglycine and triethanolamine-HCl)
at high concentrations inhibited the solubilised placental
enzyme (Pig. ). An increase in the ionic strength of
the incubation medium by the addition of KCl also produced
a similar inhibitory pattern (Pig. Thus the effect
of phosphate was not a specific one, say by competing with
the phosphate groups of NADPH (Table J^.l) but was part of a
general effect of salt concentration of the medium. The
inhibitory effect was found to be reversible since after
dialysis of the enzyme yfcich had been subjected to a high
salt concentration, enzymic activity was restored (Table
I4..2), An increase in ionic strength produces an increase
in hydrophobic bonding. The degree of such bonding is
likely to be very important for the activity of solubilised
lipophilic enzyme systems. This effect of salt concentration
is not of physiological importance since the enzymic activity
of native placental mitochondria is not affected by increases
in the phosphate concentration (Table I4..3). Scholan (1969)
observed that the liver microsomal cholesterol 7a-hydroxylase
was insensitive to increases in the phosphate concentration.
Thus membrane-bound sterol hydroxylases appear to be pro¬
tected from the inhibitory effect of high salt concentration,
presumably by their membrane environment.
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Simpson and Boyd (1966) have shown that the
cholesterol side-chain cleavage enzyme present in bovine
adrenocortical mitochondria is inhibited by carbon monoxide.
Carbon monoxide inhibition and its reversal by light
implicates an iron-containing catalyst (Warburg, 191+9)
in the cholesterol side-chain cleavage reaction. Cytochrome
P-i+50, some other haemoprotein or even a non-haem iron com¬
ponent could be the site of the CO inhibition. Simpson and
Boyd (1967a) showed from an action spectrum of the ligjht
reversal that cytochrome P-l+50 was indeed the CO-sensitive
component of the cholesterol side-chain cleavage system of
the adrenal mitochondrial preparations. The steroid 110-
and 18-hydroxylases of adrenal mitochondria (Harding et al.,
196>3;■' Greengard et al., 1967) as well as the steroid 21-
hydroxylase of adrenal microsomes (Estabrook et al,, 1963)
had displayed a ligjht reversible carbon monoxide sensitivity.
Photochemical action spectra confirmed the involvement of
cytochrome P-l+50. Thus the adrenal cholesterol side-chain
cleavage enzyme appeared to be very similar to the other
adrenal steroid hydroxylases. The present studies show
the placental mitochondrial cholesterol side-chain cleavage
enzyme is inhibited by carbon monoxide. It was found that
using an atmosphere containing carbon monoxide and oxygen
in the ratio 1'1+:1 produced a 50% inhibition of the cholesterol
side-ohain cleavage activity of an extract (105,000 g. x
60 min.) of sonicated placental mitochondria (Pig. 5*2).
The Warburg partition constant, K, for the placental cholesterol
side-chain cleavage system of l-i+ (Pig. 5.3) is very similar
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to the K values reported for the adrenal cholesterol side-
chain cleavage system by Simpson and Boyd (1966) and by
Harding et al» (1969) when K values between 0*8 and 2*0 were
reported. The K value for cytochrome P-450 is very
different to those of haemoglobin and cytochrome oxidase
which are 1*8-8*0 x 10"^ and 10-20 respectively (Keilin and
Wang, 1946). Light reversal studies showed that the carbon
monoxide inhibition was light reversible and that the most
effective light wave-length was around 450 nm (Tables 5.1 and
5.2). Thus cytochrome P-450 appeared to be involved in the
placental cholesterol side-chain cleavage reaction, and
thus must have been present in the enzyme preparations.
dhen the solubilised enzyme preparations were examined
for the presence of cytochrome P-450 using the carbon mono¬
xide-reduced difference spectrum technique developed by
Omura and Sato (196I|.a), virtually no cytochrome P-450 was
detectable. The spectral determinations were complicated
throughout this study by the presence of haemoglobin which
reacts with carbon monoxide yielding a spectral absorption
maximum at 420 nm, the same as that of cytochrome P-420, the
inactive form of cytochrome P-450. Human placenta is a
very vascular tissue and removal of the last traces of blood
is very difficult. Though perfusion of the foetal side via
the umbilical cord is possible, perfusion of the maternal
side is not possible once the tissue is detached from the
uterine wall. Figure 5*1(a) shows a typical carbon monoxide-
reduced difference spectrum of a solubilised enzyme preparation.
Large amounts of haemoglobin relative to the cytochrome P-450
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produces a spectrum which could possibly mask the cyto¬
chrome P-I4.5O absorption. However, examination of the
particulate material which remained after the extraction of
the lyophilised placental mitochondria showed that this
fraction contained cytochrome P-i+,50 as well as haemoglobin
and possibly cytochrome P-l|20 (Pig. 5* 1(b)). Thus the bulk
of the placental mitochondrial cytochrome P-I4.5O was firmly
associated with the particulate phase. It appeared that the
cholesterol side-chain cleavage activity was distinct from
the bulk of the cytochrome P-i;50. Simpson (196?) observed
a similar partition in studies on the solubilised cholesterol
side-chain cleavage enzyme from adrenocortical mitochondrial
sonicates. In that work the anomaly was resolved when it
was found that although part of the enzyme had been 1solubilised*,
the bulk of the enzyme was still in the particulate phase.
In the present study, a similar argument probably applies but
could not be tested due to the presence of the endogenous
inhibitor associated with the particulate material.
Although Juchau et al., (1968) failed to detect cyto¬
chrome P-I4.5O in 3-raonth placental tissue and suggested some
other component to be involved in placental drug metabolism,
Meig^s and Ryan (1968) detected cytochrome P-I4.5O in both
placental mitochondria and microsomes. These workers
observed that cholesterol side-chain cleavage in this tissue
was inhibited by carbon monoxide in the dark and that light
partially reversed this inhibition. This present study has
confirmed these observations and further shown almost
certainly that cytochrome P-i^O is the 00-sensitive component.
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This present study reported a Warburg partition
constant, K, of close to unity for the carbon monoxide
inhibition of the placental mitochondrial cholesterol side-
chain cleavage reaction. The enzyme source was a sonicated
placental mitochondrial extract. The light reversal studies
were carried out using a mitochondrial acetone powder extract
since their greater enzymic activity allowed shorter incubation
periods. However, using the acetone powder extracts, a carbon
monoxide to oxygen ratio of 5:1 was required to produce an
approximately 30$ inhibition of the enzymic activity (Table
3.1). Meigs and Ryan (1968) using a placental mitochondrial
acetone powder extract observed an approximately 60$
inhibition of cholesterol side-chain cleavage activity using
a carbon monoxide to oxygen ratio of 10:1. A similar
situation has been reported for the adrenal steroid ll|3-hy-
droxylase. Gammer et al., (1968) found a K value of
approximately unity whereas Harding et al. (1969) obtained
K values in the region of 3. Estabrook et al. (1968) also
observed a significant variation of the partition constant,
K, for the carbon monoxide inhibition of aminopyrine de-
methylation by liver microsomes. Estabrook and coworkers
found that the microsomal demethylation of aminopyrine was
less inhibited by carbon monoxide as the rate of electron
flux was decreased. The rate of electron flux was varied by
modifying the rate of NADPH generation. They also noted
that Warburg and Kubowitz (1929) in describing the require¬
ments for demonstrating the CO inhibition of an oxidase
reaction, had discussed the influence of the rate of electron
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flux through the electron transport system on the extent
of the inhibition observed with carbon monoxide. Cooper
et al., (1968) also required saturating levels of the reducing
system to establish the CO-inhibition of reconstituted steroid
110-hydroxylase preparations. Saturating levels of the
reducing system required molar ratios of non-haem iron
protein to flavoprotein to cytochrome P-i|50 of 50:1:1,
i.e. a large excess of the non-haem iron protein.
A dependence of the system on the rate Of electron flux could
therefore explain the variations in the value of the partition
constant for a particular hydroxylase.
The cytochrome P-i^O content of lyophilized placental
mitochondria was found to be about 0*05 nmole per mg. mito¬
chondrial protein. The cytochrome P-ip20 content was found
to be approximately 0*07 nmole per mg. mitochondrial protein.
The cytochrome ?-l\20 content was estimated by subtracting the
absorption of the oxidised haemoprotein-CO complex (at l±20 nm)
from that of the reduced haemoprotein-C0 complex (at 1+20 nm)
since only the reduced form of cytochrome P-I420 reacts with CO.
This is a very approximate method of estimating cytochrome
P-i|20. Meigs and Ryan (1968) found that the cytochrome
P-I|.50 content of native placental mitochondria was
0*12 nmoles per mg. mitochondrial protein and the cyto¬
chrome P-ipSO content, 0*06 nmoles per mg. mitochondrial
protein. Thus the present estimations are slightly
lower than those of Meigs and Ryan and apparently some of
the cytochrome P-I4.5O has undergone degradation to cytochrome
P-i420 during the lyophilization procedure. In the present
study, cytochrome P-i|50 could not be detected in native
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placental mitochondria due to large amounts of haemoglobin.
Meigs and Ryan (1968) partially overcame this difficulty
by perfusing the tissue prior to homogenisation. Such a
perfusion was not very successful in the present studies.
The effect of steroid substrates such as 20a-hydroxy-
cholesterol and 11-deoxycorticosterone on the placental mito¬
chondrial P-J4.5O was investigated. However, the low cyto¬
chrome P-I4.5O content together with turbidity problems did
not permit any conclusions to be drawn, i.e. whether the
cytochrome P-450 was in the high-spin or low-spin state.
After the solubilisation of the placental mitochondrial
cholesterol side-chain cleavage enzyme system, attempts at
the separation and the identification of the protein com¬
ponents of the soluble enzyme system were carried out.
Morrison et al. (1965) had attempted to separate the components
of the placental cholesterol side-chain cleavage enzyme system
using ammonium sulphate fractionation and Sephadex G-200 gel
chromatography but with negative results.
The soluble mitochondrial preparations were chromato-
graphed on Sephadex G-200, yielding three fractions (Pig. 5-5)•
Fractions I and II were both required for maximum activity
(Table 5»U)» Fraction I contained a haem iron protein
(Pig. 8.5) aud fraction II was heavily contaminated with
haemoglobin. Fraction IH was not required for enzymic
activity and was inhibitory towards the enzymic activity.
Fraction II was rechromatographed on DEAE-Sepahdex (A-25)
using a salt gradient (Pig. 5*6). Two further fractions
were identified, one displaying NADPH diaphorase activity
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(flavoprotein) and the other containing a non-haem iron
protein (Pig. 5*6). Fraction I, the flavoprotein fraction
and the non-haem iron protein were all required for enzymic
activity (Table 5*5)» although the recovered aotivity was low.
The combination of fraction I and the non-haem iron protein
fraction also had a small amount of cholesterol side-chain
cleavage activity, probably due to the contamination of
fraction I with flavoprotein.
Omura et al. (1966) isolated three protein components
from the steroid 11&-hydroxylase of adrenocortical mito¬
chondria. These were identified as cytochrome P-lj.50# flavo¬
protein and a non-haem iron protein (adrenodoxin) and all
were required for the 11g-hydroxylase aotivity. They
proposed that in this hydroxylation the electron flow tes
NADPH > flavoprotein > non-haem iron protein > cytochrome
P-ij.50. Simpson and Boyd (1967b) isolated three similar
protein components required for the cholesterol side-chain
cleavage enzyme system of bovine adrenocortical mito¬
chondria.
In the present studies the haem protein component of
fraction I is at least in part cytochrome P-I4.5O, although the
cytochrome P-lj.50 content of this fraction must be very low
since it could not be detected using the reduced carbon mono¬
xide difference spectrum technique (Omura and Sato, 196i[.a).
The failure to detect the presence of cytochrome P-J4.5O was
not unexpected since the original solubilised extract con¬
tained no significant amount of this cytochrome (Pig. 5»la)«
However, the light reversal studies of the carbon monoxide
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inhibition of the enzymic activity (Table 5«2) indicate
cytochrome P-J4.5O to be a component of the enzyme system. By
comparison with the studies of Simpson and Boyd (1967b),
cytochrome P-l|50 should be located in fraction I. Fraction II
contained both the flavoprotein and the non-haem iron
components. Thus the placental enzyme appeared to be very
similar to the adrenal cortex enzyme studied by Simpson and
Boyd (1967b).
The flavoprotein was also present in small amounts in
the solubilised enzyme (Fig. 5*5)• The flavoprotein chromato-
graphed on DEAE-Sephadex together with haemoglobin and so was
very contaminated.
The non-haem iron containing fraction was also present
in relatively small amounts and spectral observations on the
fraction were not informative due to the small amount of
material available. Billiar and Little (1969) have
recently isolated placental and liver mitochondrial factors
which supported steroid 113-hydroxylation in the presence of
bovine adrenal mitochondrial particles. The non-haem iron
proteins of testis and ovary, which are known to be similar
to adrenodoxin, can similarly support steroid 113-hydroxy-
lation (Kimura and Ohno, 1968). Billiar and Little (1969),
however, found that although the placental and liver factors
had similar chromatographic properties on DEAE-cellulose
to adrenodoxin, they did not contain non-haem iron or acid-
labile sulphur. The present study has shown that placental
mitochondria do contain a protein which has non-haem iron
and acid-labile sulphur. The placental protein, as prepared
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in this investigation, contained approximately 2 parts non-
haem iron to 1 part labile sulphur compared to adrenodoxin
which contains approximately equal parts of non-haem iron
and labile sulphur (Kimura, 1968). Possibly, part of the
labile sulphur has been shed during the purification procedure.
It is apparent that placental mitochondria do contain
protein components similar to those involved in the electron
transport system associated with adrenal steroid hydroxy-
lation. Thus the placental cholesterol side-chain cleavage
enzyme system appears to be very similar to the adrenal
and ovarian enzymes. (Simpson and Boyd, 1967b; Sulimovici
and Boyd, 1968b). The placental components, however, appear
to be present in much smaller amounts than in the adrenal
cortex. This is interesting because in vivo studies suggest
that the placenta at full term may be degrading about 300 mg.
cholesterol to progesterone per 2l± hours (Pearlman, 1957).
Recovery of cholesterol side-chain cleavage activity
after DEAE-Sephadex chromatography was low (Table 5*5)•
Sulimovici (1968) observed a similar loss of enzymic activity
after fractionation of the ovarian enzyme. DEAE-Sephadex
chromatography, therefore, is apparently harmful to one (or
more) of the protein components. An alternative explanation
can be attributed to a diluted reconstituted enzyme system
since a two-fold dilution of each component of a three
component system should produoe an overall eight-fold decrease
of enzymic activity. Cooper et al. (1968) found that the
activity of a reconstituted adrenal steroid 110-hydroxylase
system was fully restored only when the molar ratios of non-
haem iron protein to flavoprotein to cytochrome P-I4.5O were
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about 50:1:1. They suggested that the large excess of
non-haem iron protein required might possibly be related
to the low redox potential of cytochrome P-ij50 (about — 0*I4. V.).
Since the redox potential of the NADPH/iTADP+ system is about
-0*3 V and that of the reduced/oxidised adrenodoxin is
about zero (Kimura, 1968), the overall redox system could
possibly be rather sluggish. Hence, there could be a
requirement for a large excess of the non-haem iron protein.
Such a large excess of placental non-haem iron protein was
not used in this investigation due to the small amount of the
protein present in placental mitochondria.
The solubilised enzyme preparations, especially those
from lyophilized placental mitochondria, contained considerable
33-ol dehydrogenase and A^-3-ketosteroid isomerase activity
(Table 3.13)» After Sephadex G-200 chromatography, the
bulk of this dehydrogenase activity was associated with the
first fraction eluted, i.e. the high molecular weight
material eluted in the void volume (Table 5*6). Thus the
dehydrogenase-isomerase was firmly associated with very hi^b.
molecular weight components. This was evidence for the mito¬
chondrial location of these enzymes normally assumed to be
of microsomal origin. Koide and Torres (1965) have suggested
a possible bimodal distribution of these enzymes.
Mixed-function oxidases possess both interesting and
unusual properties. The hydroxylation reaction is virtually
irreversible and thus the enzymes involved are of considerable
significance as control steps of metabolism. Hydroxylation
reactions are Energetically expensive* since NADPH is consumed.
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Thus steroid hydroxylations involve the coupling of two
exergonic reactions
RH » R. OH
and NADPH > NADP+
This implies that enzymic hydroxylation reactions have a
rather high activation energy. The activation energy for
the placental cholesterol side-chain cleavage enzyme was
found to be 18'ij. +_ 2*5 kcal.mole This is of the same
order as that of the liver microsomal cholesterol 7&-hydroxy-
lase which was found to be 22 + I4. kcal mole"""1" (Boyd, 1970).
It seems probable, therefore, that the activation process
is similar for each of these hydroxylases. Molecular oxygen
is a rather inert molecule. The oxygen molecule has to
accept two electrons in the 'activation* process. If, as
seems likely, this process occurs stepwise, 0^'~ will possibly
be an intermediate (see Bray, 1970). However Sih (1969) has
objected to the postulation that the perferryl ion FE(II)-02
is the so-called "active oxygen", since it is known that,
in general, oxygen complexes of d^-transition metals are
kinetically stable toward oxidation of unactivated carbon-
hydrogen bonds. This is because in F©(II)-0£, both (<r) and
(rr) bonding occur. This strengthens the metal-ligand bond
and contributes to the unusual stability of the Fe(II)-02
complex. Sih has suggested that a much more reactive species
would be the hydroperoxo complex of ferrous ion [Fe(II)-0-0H] •
Within this complex, all the p orbitals of oxygen are
occupied and the metal-ligand interaction is weaker. This
facilitates the rupture of the oxygen-oxygen bond and
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generates the ferryl ion complex Fe(II)-0: which is a
highly reactive species (Hamilton et al., 1966).
The direct involvement of NADPH is the formation of
[Fe(II)-O-OH]~ in steroid hydroxylation had been proposed
earlier by Haya*i)o (1962). NADPH has a dual function in
this mechanism. Reduced NADP serves in an accessory
capacity by keeping the autoxidisable P-lj.50 in the reduced
state by means of the NADPH-cytochrome P-ij.50 reductase
system, a sequence which is steroid independent. Secondly,
NADPH is directly involved in the steroid hydroxylation
reaction to generate the hydroperoxo complex [Fe(II)-O-OH]".
Experimental evidence in favour of the dual role of NADPH
in the lip-hydroxylation of deoxycorticosterone has been
obtained (Sih et al., 1968). The existence of the transient
[Fe(II)-O-OH]~ species still remains to be demonstrated.
Further developments in the purification and examination of
cytochrome P-lj.50 are required for the elucidation of the
mechanism of steroid hydroxylation.
The biosynthetic pathway by which pregnenolone is
produced from cholesterol reportedly involves two hydroxy-
lated sterol intermediates, 20a-hydroxycholesterol and 20a,
22R-dihydroxycholesterol. A search was carried out
in the present study of the placental cholesterol side-chain
cleavage reaction for the presence of possible intermediates
between cholesterol and pregnenolone. However, none were
ever detected. The evidence for the existence of these
compounds is based mainly on incubation studies in which
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synthetic samples of the two proposed intermediates were
converted more efficiently than cholesterol into pregnenolone.
(Shimizu et_al., 1961; 1962). Neither of these compounds
has been isolated from natural sources in adequately
characterised form. Chaudhuri et al. (1962) also proved
that 22R-hydroxycholesterol could be converted into preg¬
nenolone by a bovine adrenal preparation. This finding
complicated the scheme since it made it necessary to postulate
more than one pathway between cholesterol and pregnenolone,
and this, as has been pointed out by Simpson and Boyd (1967a)
is unlikely. Recently, Burstein and Gut (1969) have shown
that the pathway involving 22R-hydroxycholesterol is probably
much more significant than that involving 20a-hydroxycholesterol.
Although using adrenal mitochondrial preparations which
converted 20a-hydroxycholesterol to pregnenolone in good
yield, many workers (Koritz and Hall, 1961).; Hall and
Koritz, 1961).; Simpson and Boyd, 1967a; Lieberman et al.,
1969) have been unable to "trap" radioactivity in this
hydroxysteroid when labelled cholesterol is used as substrate
for this conversion. Simpson and Boyd (1967a) suggested
that the intermediates remained enzyme-bound. Lieberman
et al. (1969) have considered the possibility that the inter¬
mediates might resemble some of the transitory free radicals
involved in the autoxidation of isobutane (Mayo, 1968). The
intermediates in this reaction are postulated to be:
R^CH * R3C* > R^G-O-O*
( R = GH J J




In this scheme, 20a-hydroxycholesterol will not be an
intermediate even though, by its ready conversion into a
product which behaves like an alkoxy radical, it may be
efficiently converted into pregnenolone. Lieberman et al.
(1969) support this postulation by demonstrating that the
treatment of 20a-hydroxycholesterol-3-acetate with lead
tetra-acetate (a reagent which abstracts H* from hydroxyl
groups) results in the formation of pregnenolone acetate
which undoubtedly arose by fragmentation of the alkoxy
radical. Van Lier and Smith (1968) have reported that
autoxidation of cholesterol (most likely mediated by free
radical intermediates) led to the formation of several products
among *h.ich were cholesterol-20a-hydroperoxide, cholesterol-
25-hydroperoxide and pregnenolone. The possibility exists
that the mechanisms involved in this process might be similar
to those involved in steroid hormone production from
cholesterol. It is well accepted that oxygen radicals
are involved in sane biological oxidations and hydroxy-
latlons (Staudinger, 1966).
Shimizu (1968) has reported that the side-chain cleavage
of 20a-22R-dihydroxycholesterol still retains a requirement
for NADPH and molecular oxygen. Thus the metabolism of
20a-hydroxycholesterol, 22R-hydroxycholesterol and 20a,22R-
dihydroxycholesterol, might reflect not the intermediacy of
these compounds but lack of specificity of the enzyme.
The intermediate problem will not be resolved until the
Intermediates are formed from the natural precursor by a single
purified enzyme. Details of the stoiohiometry of the
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reaction would be of considerable value to the solution
of this problem.
This investigation has been concerned with a study
of the human placental cholesterol side-chain cleavage enzyme.
The enzyme was found to have the characteristics of a mono-
oxygenase requiring NADPH and molecular oxygen. The enzyme
was located in the mitochondrial fraction. The intra-
mitochondrial reducing equivalents source for NADPH gener¬
ation appeared to be succinate mediated possibly by an
energy-linked trans-hydrogenase coupled with reversed electron
flow. Solubilisation of the enzyme system was achieved.
These studies were complicated by the activation of an endo¬
genous inhibitor of the enzyme, which appeared to be
mitochondrial phospholipid, when the placental mitochondria
were disrupted. The solubilised enzyme system was
fractionated into three components, cytochrome P-J4.5O, a
flavoprotein and a non-haem iron protein. The presence
of all the three components was essential for enzymic
activity. Thus the placental enzyme appeared very similar
to the adrenocortical enzyme, except that the concentrations
of the enzyme components in placental mitochondria were much
les3 than those in adrenal mitochondria.
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APPENDIX
The following chemicals were purchased from the
Sigma Chemical Co. - NADP+ monosodium salt, G6P disodium
salt, G6P dehydrogenase, NAEH, NAD+, 2,6-dichlorophenol
indophenol, ATP, bathophenanthroline sulphonate (sodium salt),
0-mercapto-ethylamine.
Silica gel H was purchased from Merck.
[Ip-^C] Cholesterol and [i^-^C ] pregnenolone were
purchased from the Radiochemical Centre, Amersham.
The purified lecithin and phosphatidyl ethanolamine
were supplied by Lipid Products, Epsom.
PPO scintillation grade and POPOP scintillation grade
were from the Packard Instrument Co. Inc.
Sephadex G-200 and DEAE-Sephadex (A-25) were purchased
from Pharmacia, Uppsala.
Polyethylene glycol (Carbowax 20M) was obtained from
the Union Carbide Chemical Co.
Standard steroids were supplied by Organon.
All other reagents and solvents were analar reagent
grade, with the exception of toluene and acetone. Toluene
was washed with conc. sulphuric acid and water, and dried
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The Presence of an Endogenous Inhibitor of
the Cholesterol Side-Chain-Cleavage System
of Human Placenta
By J. I. Mason and G. S. Boyd. (Department of
Biochemistry, University of Edinburgh, Edinburgh
EH8 9AO, U.K.)
The presence of an active cholesterol side-cliain-
cleavage enzyme system in human placental mito¬
chondria was reported by Morrison, Meigs & Ryan
(1965). Solubilization of the enzyme was achieved
from an acetone-dried powder preparation. These
workers noted that thorough treatment of the powder
with ether was necessary to obtain active prepara¬
tions.
The adrenal cholesterol side-chain-cleavage enzyme
and the steroid 11/3-hydroxylase systems possess
similar characteristics (see Omura, Sanders, Esta-
brook, Cooper & Rosenthal, 1966; Simpson & Boyd,
1967a). Sharma, Forchielli & Dorfman (1962)
reported the preparation of a soluble steroid 11/3-
hydroxylase from bovine adrenocortical mitochon¬
dria. They observed that ultrasonic treatment
followed by high-speed centrifugation resulted in
increased enzymic activity as compared with the
initial ultrasonically treated preparation. This
suggested the presence of an 11/3-hydroxylase
inhibitor associated with the insoluble particles.
We have investigated various methods for the
solubilization of the cholesterol side-chain-cleavage
enzyme system present in human term-placental
mitochondria. The assay was performed as described
by Simpson & Boyd (19676). Native placental
mitochondria converted [4-14C]cholesterol into pro¬
gesterone with a 4-8% conversion in lh. Ultrasonic
disruption of the mitochondria produced a decrease
in enzymic activity. However, after ultracentrifuga-
tion (105000gr for lh) of the sonicated preparation,
increased enzymic activity was shown in the super¬
natant. Similarly, freeze-drying of the sonicated
mitochondria resulted in a preparation that did not
show maximal activity until ultracentrifugation at
lOoOOOg' for at least 90min. A mitochondrial
acetone-dried-powder preparation exhibited a similar
phenomenon.
The results suggested the presence of an enzyme
inhibitor associated with the insoluble material. It
was heat-stable and firmly bound to the insoluble
particles, but could be extracted with cliloroform-
methanol (2:1, v/v). Prolonged acetone treatment
of the mitochondria also resulted in removal of the
inhibitor. The main components present in the
acetone wash were phospholipid (mainly phospha¬
tidylcholine and phosphatidylethanolamine) and
cholesterol. The phospholipid fraction was found to
be inhibitory.
The effect of authentic phosphatidylcholine and
phosphatidylethanolamine on the enzymic activity
was investigated. The former was found to be the
more potent inhibitor of the enzymic activity.
Mitochondrial phospholipid, together with other
factor(s) present in the placental mitochondria,
inhibited cholesterol side-chain-cleavage activity.
The mechanism may involve sequestration of the
cholesterol substrate in some mieellar or lipoprotein
form.
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